Listado de ensayos

"Natural History" Study of COROIDEREMIA

Estado: Reclutando Categoria: Coroideremia Resultado: Resultados no disponibles

Patología

COROIDEREMIA

Tratamiento

Other: Observation

Localizaciones

Retina Foundation of the Southwest, Dallas, Texas, United States Baylor College of Medicine, Ophthalmology-Cullen Eye Center, Houston, Texas, United States Moran Eye Center, University of Utah, Salt Lake City, Utah, United States University of Alberta, Edmonton, Alberta, Canada

A Safety Study of Retinal Gene Therapy for COROIDEREMIA With Administration of BIIB111

Estado: Activo, No reclutando Categoria: Coroideremia Resultado: Resultados no disponibles

Patología

COROIDEREMIA

Tratamiento

Drug: BIIB111

Localizaciones

Research Site, Miami, Florida, United States Research Site, Boston, Massachusetts, United States Research Site, Cincinnati, Ohio, United States Research Site, Portland, Oregon, United States Research Site, Paris, France Research Site, T bingen, Germany

Natural Disease Progression in Participants With COROIDEREMIA

Estado: Activo, No reclutando Categoria: Coroideremia Resultado: Resultados no disponibles

Patología

COROIDEREMIA

Tratamiento

Other: No Intervention

Localizaciones

Research Site, San Francisco, California, United States

REP1 Gene Replacement Therapy for COROIDEREMIA

Estado: Activo, No reclutando Categoria: Coroideremia Resultado: Resultados no disponibles

Patología

COROIDEREMIA

Tratamiento

Genetic: AAV-mediated REP1 gene replacement

Localizaciones

Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

Safety and Dose Escalation Study of AAV2-hCHM in Subjects With CHM (COROIDEREMIA) Gene Mutations

Estado: Activo, No reclutando Categoria: Coroideremia Resultado: Resultados no disponibles

Patología

COROIDEREMIA (COROIDEREMIA) mutacion en el gen CHM

Tratamiento

Biological: AAV2-hCHM

Localizaciones

Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States University of Pennsylvania, Philadelphia, Pennsylvania, United States Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of COROIDEREMIA and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa

Estado: Reclutando por invitación Categoria: Coroideremia Resultado: Resultados no disponibles

Patología

COROIDEREMIA Retinitis Pigmentosa Ligada a X

Tratamiento

Genetic: BIIB111 Genetic: BIIB112

Localizaciones

Research Site, Gainesville, Florida, United States Research Site, Miami, Florida, United States Research Site, Cincinnati, Ohio, United States Research Site, Portland, Oregon, United States Research Site, Dallas, Texas, United States Research Site, Madison, Wisconsin, United States Research Site, Edmonton, Alberta, Canada Research Site, Helsinki, Finland Research Site, Bonn, Germany Research Site, T bingen, Germany Research Site, Oxford, United Kingdom

Study of a Suprachoroidal Retinal Prosthesis

Estado: Reclutando por invitación Categoria: Coroideremia Resultado: Resultados no disponibles

Patología

Retinitis Pigmentosa COROIDEREMIA

Tratamiento

Device: 44Ch Bionic Eye Device

Localizaciones

Centre for Eye Research Australia, Melbourne, Victoria, Australia

IRIS PILOT - Extended Pilot Study With a Retinal Implant System

Estado: Estado desconocido Categoria: Coroideremia Resultado: Resultados no disponibles

Patología

Retinitis Pigmentosa Cone-Rod Dystrophy COROIDEREMIA

Tratamiento

Device: Retinal Implant System (IRIS)

Ver informe

High Resolution Retinal Imaging

Estado: Reclutando Categoria: Coroideremia Resultado: Resultados no disponibles

Patología

Stargardts Retinitis Pigmentosa Degeneracion Macular Asociada a la Edad COROIDEREMIA Atrofia Geografica

Tratamiento

Procedure: Retinal imaging

Localizaciones

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Inherited Retinal Degenerative Disease Registry

Estado: Reclutando Categoria: Coroideremia Resultado: Resultados no disponibles

Patología

Distrofias hereditarias oculares Distrofia de retina Acromatopsia Sindrome Bardet-Biedl Sindrome Bassen-Kornzweig Enfermedad de Batten Enfermedad de Best Distrofia Choroidal COROIDEREMIA Distrofia de conos Y 18 mas

Localizaciones

Foundation Fighting Blindness, Columbia, Maryland, United States

Gene Therapy for Blindness Caused by Choroideremia

Estado: Completado Categoria: Coroideremia Resultado: No tiene resultados

Patología

Coroideremia

Tratamiento

MEDICACION: rAAV2.REP1

Localizaciones

Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom Oxford Radcliffe Hospitals NHS Trust, Oxford, United Kingdom Eye Unit, Southampton University Hospitals NHS Trust, Southampton, United Kingdom

Natural History of the Progression of Choroideremia Study

Estado: Completado Categoria: Coroideremia Resultado: No tiene resultados

Patología

coroideremia

Localizaciones

Research Site, Los Angeles, California, United States Research Site, Miami, Florida, United States Research Site, Baltimore, Maryland, United States Research Site, New York, New York, United States Research Site, Portland, Oregon, United States Research Site, Dallas, Texas, United States Research Site, Madison, Wisconsin, United States Research Site, S o Paulo, Brazil Research Site, Edmonton, Alberta, Canada Research Site, Montr al, Canada and 10 more

Efficacy and Safety of BIIB111 for the Treatment ofcoroideremia

Estado: Completado Categoria: Coroideremia Resultado: No tiene resultados

Patología

coroideremia

Tratamiento

Genetic: BIIB111

Localizaciones

Research Site, Los Angeles, California, United States Research Site, Miami, Florida, United States Research Site, Baltimore, Maryland, United States Research Site, New York, New York, United States Research Site, Cincinnati, Ohio, United States Research Site, Portland, Oregon, United States Research Site, Dallas, Texas, United States Research Site, Madison, Wisconsin, United States Research Site, Montr al, Canada Research Site, Vancouver, Canada and 8 more

THOR - T bingen Choroideremia Gene Therapy Trial

Estado: Completado Categoria: Coroideremia Resultado: No tiene resultados

Patología

coroideremia

Tratamiento

Genetico: rAAV2.REP1

Localizaciones

University Hospital Tuebingen, Center for Ophthalmology, Tuebingen, Germany

The Short-term Effects of Simvastatin on the Vision of Males Affected by Choroideremia

Estado: Completado Categoria: Coroideremia Resultado: No tiene resultados

Patología

coroideremia

Tratamiento

Medicacion: Simvastatin

Localizaciones

Ophthalmology Research Office, University of Alberta, Edmonton, Alberta, Canada

Pilot Study of a Suprachoroidal Retinal Prosthesis

Estado: Completado Categoria: Coroideremia Resultado: No tiene resultados

Patología

Retinitis Pigmentosa coroideremia

Tratamiento

Dispositivo: prototipo de pr tesis de retina supracoroidea de visi n amplia

Localizaciones

Nicta / Data61, Canberra, Australian Capital Territory, Australia Centre for Eye Research Australia, East Melbourne, Victoria, Australia

Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy

Estado: Completado Categoria: Coroideremia Resultado: No tiene resultados

Patología

Retinitis Pigmentosa Distrrofia de retina coroideremia

Tratamiento

Dispositivo: Sistema de implante de retina inteligente

Localizaciones

Medical University of Graz, Graz, Austria Clinique Ophtalmologique du CHU de Nantes, Nantes, France Hopital des Quinze Vingts/Fondation Ophtalmologique A. De Rothschild, Paris, France Dept. of Ophthalmology, University of Bonn, Bonn, Germany Klinik und Poliklinik f r Augenheilkunde Hamburg-Eppendorf, Hamburg, Germany

Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy

Estado: Completado Categoria: Coroideremia Resultado: No tiene resultados

Patología

Retinitis Pigmentosa Cone Rod Dystrophy coroideremia

Tratamiento

Dispositivo: Sistema de implante de retina inteligente

Localizaciones

Medical University of Graz, Graz, Austria Clinique Ophtalmologique du CHU de Nantes, Nantes, France CHU Nimes, Service Ophtalmologie (France)/ Hopital Gui de Chauliac, CHU Montpelier, (France), Nimes, France Hopital des Quinze Vingts/Fondation Ophtalmologique A. De Rothschild, Paris, France Dept. of Ophthalmology, University of Bonn, Bonn, Germany Universit ts KlinikumKlinik f r Augenheilkunde Freiburg, Freiburg, Germany Klinik und Poliklinik f r Augenheilkunde Hamburg -Eppendorf, Hamburg, Germany Instituto de Microcirugia Ocular, Barcelona, Spain Moorfields Eye Hospital, London, United Kingdom

Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT Alpha AMS

Estado: Completado Categoria: Coroideremia Resultado: No tiene resultados

Patología

Retinal Degeneration Inherited Retinal Dystrophy Primarily Involving Sensory Retina

Tratamiento

Dispositivo: Sistema de implante de retina inteligente

Localizaciones

Clinique Saint Jean, Montpellier, H rault, France Centre Hospitalier Universitaire La Mil trie de Poitiers, Poitiers, Vienne, France

A Study to Assess COROIDEREMIA (CHM) Health Outcomes

Estado: Reclutando Categoria: Coroideremia Resultado: Resultados no disponibles

Patología

COROIDEREMIA

Tratamiento

Other: No Intervention

Localizaciones

Research Site, Los Angeles, California, United States Research Site, San Francisco, California, United States Research Site, Coral Gables, Florida, United States Research Site, Gainesville, Florida, United States Research Site, Portland, Oregon, United States Research Site, Pittsburgh, Pennsylvania, United States Research Site, Dallas, Texas, United States Research Site, Madison, Wisconsin, United States

An Open Label Clinical Trial of Retinal Gene Therapy for COROIDEREMIA

Estado: Activo, No reclutando Categoria: Coroideremia Resultado: Resultados no disponibles

Patología

COROIDEREMIA

Tratamiento

Genetic: rAAV2.REP1 vector

Localizaciones

University of Alberta, Edmonton, Alberta, Canada

Dose Escalation Study of Intravitreal 4D-110 in Patients With COROIDEREMIA

Estado: Reclutando Categoria: Coroideremia Resultado: Resultados no disponibles

Patología

COROIDEREMIA

Tratamiento

Biological: 4D-110

Localizaciones

Retina Foundation of the Southwest, Dallas, Texas, United States Moran Eye Center, University of Utah, Salt Lake City, Utah, United States

Choroideremia Gene Therapy Clinical Trial

Estado: Completado Categoria: Coroideremia Resultado: Tiene resultados

Patología

coroideremia

Tratamiento

BiologiCO: Injecci n de AAV2-REP1 (10e11 vg)

Localizaciones

Bascom Palmer Eye Institute, University of Miami, Miami, Florida, United States

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Estado: Reclutando Categoria: RP (Autosómico Dominante) Resultado: Sin resultados

Patología

Rare Disorders Undiagnosed Disorders Disorders of Unknown Prevalence Cornelia De Lange Syndrome Prenatal Benign Hypophosphatasia Perinatal Lethal Hypophosphatasia Odontohypophosphatasia Adult Hypophosphatasia Childhood-onset Hypophosphatasia Infantile Hypophosphatasia and 286 more

Localizaciones

Sanford Health, Sioux Falls, South Dakota, United States Online Patient Enrollment System, Sydney, Australia

Transcorneal Electrical Stimulation Therapy for Retinal Disease

Estado: Completado Categoria: RP (Autosómico Dominante) Resultado: Sin resultados

Patología

RETINOSIS PIGMENTARFIA Macula Off Primary Open Angle Glaucoma Hereditary Macular Degeneration Treated Retina Detachment Retinal Artery Occlusion Retinal Vein Occlusion Non-Arthritic-Anterior-Ischemic Optic- Neuropathy Hereditary Autosomal Dominant Optic Atrophy Dry Age Related Macular Degeneration Ischemic Macula Edema

Tratamiento

Device: Transcorneal Electrical Stimulation Device: DTL-electrode attached without energy

Ver informe

Autosomal Dominant RETINOSIS Pigmentosa: Prevalence of Known Genes Identification of New Loci / Genes

Estado: Completado Categoria: RP (Autosómico Dominante) Resultado: Sin resultados

Patología

RETINOSIS PIGMENTARIA AUTOSOMICA DOMINANTE

Tratamiento

Genetic: genetic analysis

Localizaciones

CHRU Montpellier, Montpellier, France

A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant RETINOSIS Pigmentosa Due to the P23H Mutation in the RHO Gene

Estado: Reclutando Categoria: RP (Autosómico Dominante) Resultado: Sin resultados

Patología

RETINOSIS PIGMENTARIA AUTOSOMICA DOMINANTE Eye Diseases Eye Diseases, Hereditary Retinal Dystrophies Retinal Disease RETINOSIS Vision Tunnel Vision Disorders

Tratamiento

Drug: QR-1123 Other: Sham procedure

Localizaciones

Sue Anschutz-Rogers Eye Center, University of Colorado - Dept. of Ophthalmology, Aurora, Colorado, United States VitreoRetinal Associates, Gainesville, Florida, United States Shriners UK Ophthalmology - University of Kentucky, Lexington, Kentucky, United States Casey Eye Institute, OHSU, Portland, Oregon, United States Retina Foundation of the Southwest, Dallas, Texas, United States

Observational Natural History Study of Autosomal Dominant RETINOSIS Pigmentosa (adRP)

Estado: Terminado Categoria: RP (Autosómico Dominante) Resultado: Sin resultados

Patología

RETINOSIS PIGMENTARFIA

Tratamiento

Diagnostic Test: Observation

Localizaciones

Texas Retina Associates,, Dallas, Texas, United States

Trial of Oral Valproic Acid for RETINOSIS Pigmentosa

Estado: Completado Categoria: RP (Autosómico Dominante) Resultado: Tiene resultados

Patología

RETINOSIS PIGMENTARFIA

Tratamiento

Drug: Valproic Acid Drug: Placebo

Localizaciones

University of Miami, Bascom Palmer Eye Institute, Miami, Florida, United States University of Michigan, Ann Arbor, Ann Arbor, Michigan, United States Oregon Health & Science University, Portland, Oregon, United States University of Tennessee, Hamilton Eye Institute, Memphis, Tennessee, United States Retina Foundation of the Southwest, Dallas, Texas, United States University of Utah School of Medicine, Moran Eye Center, Salt Lake City, Utah, United States

Oral QLT091001 in RETINOSIS Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)

Estado: Completado Categoria: RP (Autosómico Dominante) Resultado: Sin resultados

Patología

RETINOSIS PIGMENTARFIA (RP)

Tratamiento

Drug: QLT091001

Localizaciones

Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada Royal Victoria Eye and Ear Hospital, Dublin, Ireland

Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa

Estado: Completado Categoria: RP (Ligada a X) Resultado: Sin resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: docosahexaenoic acid

Ver informe

Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR)

Estado: Reclutando Categoria: RP (Ligada a X) Resultado: Sin resultados

Patología

RETINOSIS PIGMENTARIA

Localizaciones

Shiley Eye Institute - UCSD, La Jolla, California, United States Emory Eye Centre, Atlanta, Georgia, United States Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States Kellogg Eye Center, Ann Arbor, Michigan, United States UPMC Eye Centre, Pittsburgh, Pennsylvania, United States The Hospital for Sick Children, Toronto, Canada Moorfields Eye Hospital, London, United Kingdom

Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Estado: Reclutando Categoria: RP (Ligada a X) Resultado: Sin resultados

Patología

RETINOSIS PIGMENTARIA LIGADA A X

Tratamiento

Biological: Genetic: AAV5-RPGR 4e11 Biological: Genetic: AAV5-RPGR 2e11

Localizaciones

Vitreo Retinal Associates, Gainesville, Florida, United States The Emory Eye Centre, Atlanta, Georgia, United States Boston Eye and Ear, Boston, Massachusetts, United States Univeristy of Michigan, Ann Arbor, Michigan, United States Retinal Consultants of Houston, Bellaire, Texas, United States

A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations

Estado: Aún no reclutando Categoria: RP (Ligada a X) Resultado: Sin resultados

Patología

RETINOSIS PIGMENTARIA LIGADA A X

Tratamiento

Biological: rAAV2tYF-GRK1-hRPGRco

Ver informe

Clinical Evaluation of Patients With X-linked RETINOSIS PIGMENTARIA (XLRP)

Estado: Reclutando Categoria: RP (Ligada a X) Resultado: Sin resultados

Patología

RETINOSIS PIGMENTARIA LIGADA A X

Localizaciones

Duke Eye Center, Duke University Medical Center, Durham, North Carolina, United States Casey Eye Institute, Oregon Health and Sciences University, Portland, Oregon, United States Retina Foundation of the Southwest, Dallas, Texas, United States

Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) Retinitis Pigmentosa GTPase Regulator (RPGR)

Estado: Activo, No reclutando Categoria: RP (Ligada a X) Resultado: Sin resultados

Patología

RETINOSIS PIGMENTARIA LIGADA A X

Tratamiento

Genetic: AAV2/5-RPGR

Localizaciones

Massachusetts Eye and Ear Institute, Boston, Massachusetts, United States Kellogg Eye Center, Ann Arbor, Michigan, United States UPMC Eye Center, Pittsburgh, Pennsylvania, United States Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom

A Clinical Trial of Retinal Gene Therapy for X-linked RETINOSIS PIGMENTARIA Using BIIB112

Estado: Completado Categoria: RP (Ligada a X) Resultado: Sin resultados

Patología

RETINOSIS PIGMENTARIA LIGADA A X

Tratamiento

Biological: BIIB112

Localizaciones

Research Site, Gainesville, Florida, United States Research Site, Miami, Florida, United States Research Site, Portland, Oregon, United States Research Site, Philadelphia, Pennsylvania, United States Research Site, Dallas, Texas, United States Research Site, Manchester, United Kingdom Research Site, Oxford, United Kingdom Research Site, Southampton, United Kingdom

Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations

Estado: Reclutando Categoria: RP (Ligada a X) Resultado: Sin resultados

Patología

RETINOSIS PIGMENTARIA LIGADA A X

Tratamiento

Biological: rAAV2tYF-GRK1-RPGR

Localizaciones

University of Florida, Jacksonville, Florida, United States Columbia University, New York, New York, United States Duke Eye Center, Durham, North Carolina, United States Cincinnati Eye Institute, Cincinnati, Ohio, United States Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, United States Retina Foundation of the Southwest, Dallas, Texas, United States

Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa

Estado: Inscripción por invitación Categoria: RP (Ligada a X) Resultado: Sin resultados

Patología

Choroideremia RETINOSIS PIGMENTARIA LIGADA A X

Tratamiento

Genetic: BIIB111 Genetic: BIIB112

Localizaciones

Research Site, Gainesville, Florida, United States Research Site, Miami, Florida, United States Research Site, Cincinnati, Ohio, United States Research Site, Portland, Oregon, United States Research Site, Dallas, Texas, United States Research Site, Madison, Wisconsin, United States Research Site, Edmonton, Alberta, Canada Research Site, Helsinki, Finland Research Site, Bonn, Germany Research Site, T bingen, Germany Research Site, Oxford, United Kingdom

Long Term Follow-Up Gene Therapy Study for XLRP RPGR

Estado: Reclutando Categoria: RP (Ligada a X) Resultado: Sin resultados

Patología

RETINOSIS PIGMENTARIA LIGADA A X

Tratamiento

Biological: AAV-RPGR

Localizaciones

Moorfields Eye Hospital, London, United Kingdom

DHA and X-Linked Retinitis Pigmentosa

Estado: Completado Categoria: RP (Ligada a X) Resultado: Tiene resultados

Patología

RETINOSIS PIGMENTARIA ENFERMEDAD GENETICA LIGADA A X

Tratamiento

Drug: docosahexaenoic acid OR corn/soy oil placebo

Localizaciones

Retina Foundation of the Southwest, Dallas, Texas, United States

Natural History of the Progression of X-Linked RETINOSIS PIGMENTARIA

Estado: Reclutando Categoria: RP (Ligada a X) Resultado: Sin resultados

Patología

RETINOSIS PIGMENTARIA LIGADA A X

Tratamiento

Other: Other: Assessments

Localizaciones

Research Site, Phoenix, Arizona, United States Research Site, Los Angeles, California, United States Research Site, San Francisco, California, United States Research Site, Miami, Florida, United States Research Site, New York, New York, United States Research Site, Portland, Oregon, United States Research Site, Dallas, Texas, United States Research Site, Houston, Texas, United States Research Site, Salt Lake City, Utah, United States Research Site, Madison, Wisconsin, United States and 12 more

4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)

Estado: Reclutando Categoria: RP (Ligada a X) Resultado: Sin resultados

Patología

RETINOSIS PIGMENTARIA LIGADA A X

Tratamiento

Biological: 4D-125 IVT Injection Other: Observational

Localizaciones

University of Colorado, Aurora, Colorado, United States University of Michigan Kellogg Eye Center, Ann Arbor, Michigan, United States Duke University Eye Center/Dept. of Ophthalmology, Durham, North Carolina, United States Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, United States Retina Foundation of the Southwest, Dallas, Texas, United States University of Utah John A. Moran Eye Center, Salt Lake City, Utah, United States

An Observational Study of Japanese Participants With X- linked Retinitis Pigmentosa

Estado: Aún no reclutando Categoria: RP (Ligada a X) Resultado: Sin resultados

Patología

RETINOSIS PIGMENTARIA LIGADA A X

Localizaciones

National Hospital Organization Tokyo Medical Center, Tokyo, Japan

Gene Therapy Trial for the Treatment of X-linked RETINOSIS PIGMENTARIA Associated With Variants in the RPGR Gene

Estado: Reclutando Categoria: RP (Ligada a X) Resultado: Sin resultados

Patología

RETINOSIS PIGMENTARIA LIGADA A X

Tratamiento

Biological: Genetic: AAV5-RPGR

Localizaciones

Vitreol Retinal Associates, Gainesville, Florida, United States The Emory Eye Centre, Atlanta, Georgia, United States Boston Eye and Ear, Boston, Massachusetts, United States University of Michigan, Ann Arbor, Michigan, United States Retinal Consultants of Houston, Bellaire, Texas, United States

Stem Cell Ophthalmology Treatment Study

Estado: Inscripción por invitación Categoria: Stargardt Resultado: Sin resultados

Patología

Retinal Disease Macular Degeneration Hereditary Retinal Dystrophy Optic Nerve Disease Glaucoma

Tratamiento

Procedure: RB (Retrobulbar) Procedure: ST (Subtenon) Procedure: IV (Intravenous) Procedure: IVIT (Intravitreal) Procedure: IO (Intraocular)

Localizaciones

MD Stem Cells, Westport, Connecticut, United States

Efficacy of Acupuncture in Macular Diseases

Estado: Completado Categoria: Stargardt Resultado: Tiene resultados

Patología

DEGENERACION MACULAR ASOCIAQDA A LA EDAD ENFERMEDAD DE STARGARDT DISTROFIA MACULAR

Tratamiento

Other: Acupuncture and massage

Localizaciones

IPS Fundaci n Neijing, Guarne, Antioquia, Colombia IPS Fundaci n Neijing, Medellin, Antioquia, Colombia

Phase 1 Safety Study of ALK-001 in Healthy Volunteers

Estado: Completado Categoria: Stargardt Resultado: Sin resultados

Patología

ENFERMEDAD DE STARGARDT DMAE Other Retinal Dystrophies

Tratamiento

MEDICAMENTO: ALK-001 (No generic name)

Ver informe

Pupil Dynamics and Color Vision for the Detection of Eye Diseases

Estado: Completado Categoria: Stargardt Resultado: Sin resultados

Patología

Retinitis Pigmentosa Leber's Hereditary Optic Neuropathy ENFERMEDAD DE STARGARDT

Tratamiento

Behavioral: Dynamic pupillometry sessions

Localizaciones

Centre Hospitalier National D'Ophtal mologie des Quinze- Vingts, Paris, France

Microcurrent Stimulation to Treat Macular Degeneration

Estado: Completado Categoria: Stargardt Resultado: Sin resultados

Patología

Retinal Diseases ENFERMEDAD DE STARGARDT Retinitis Pigmentosa

Localizaciones

Hawaii Cataract Laser Institute - Hilo, Hilo, Hawaii, United States Retina Institute of Hawaii, Honolulu, Hawaii, United States Hawaii Cataract Laser Institute - Maui, Kahului, Hawaii, United States Hawaii Cataract Laser Institute - Kona, Kailua-Kona, Hawaii, United States

Stem Cell Therapy for Outer Retinal Degenerations

Estado: Completado Categoria: Stargardt Resultado: Sin resultados

Patología

Age Related Macular Degeneration ENFERMEDAD DE STARGARDT Exudative Age-related Macular Degeneration

Tratamiento

Procedure: injection of hESC-RPE in suspension Procedure: injection hESC-RPE seeded in a substrate

Localizaciones

Federal University of Sao Paulo, Sao Paulo, Brazil

Oral Metformin for Treatment of ABCA4 Retinopathy

Estado: Reclutando Categoria: Stargardt Resultado: Sin resultados

Patología

ABCA4 Retinopathy ENFERMEDAD DE STARGARDT Retinal Dystrophy Retinal Degeneration

Tratamiento

MEDICAMENTO: Metformin hydrochloride

Localizaciones

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Stem Cells Therapy in Degenerative Diseases of the Retina

Estado: Estado desconocido Categoria: Stargardt Resultado: Sin resultados

Patología

Retinal Degeneration Retinitis Pigmentosa DMAE ENFERMEDAD DE STARGARDT 1

Tratamiento

Biological: Stem/progenitor cells transplantation

Localizaciones

I Department of Ophthalmology, Szczecin, Poland

Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision

Estado: Reclutando Categoria: Stargardt Resultado: Sin resultados

Patología

Low Vision Retinitis Pigmentosa ENFERMEDAD DE STARGARDT 1 ENFERMEDAD DE STARGARDT 3 ENFERMEDAD DE STARGARDT 4 Albinism

Tratamiento

Device: Virtual Reality Headset based tests

Localizaciones

NI Clinical Research Facility, Belfast, Northern Ireland, United Kingdom

Stem Cell Ophthalmology Treatment Study II

Estado: Reclutando Categoria: Stargardt Resultado: Sin resultados

Patología

Retinal Disease Age-Related Macular Degeneration Retinitis Pigmentosa ENFERMEDAD DE STARGARDT Optic Neuropathy Nonarteritic Ischemic Optic Neuropathy Optic Atrophy Optic Nerve Disease Glaucoma Leber Hereditary Optic Neuropathy and 8 more

Tratamiento

Procedure: Arm 1 Procedure: Arm 2 Procedure: Arm 3

Localizaciones

MD Stem Cells, Westport, Connecticut, United States MD Stem Cells, Coral Springs, Florida, United States Fakeeh University Hospital, Dubai, United Arab Emirates

Inherited Retinal Degenerative Disease Registry

Estado: Reclutando Categoria: Stargardt Resultado: Sin resultados

Patología

Eye Diseases Hereditary Retinal Disease Achromatopsia Bardet-Biedl Syndrome Bassen-Kornzweig Syndrome Batten Disease Best Disease Choroidal Dystrophy Choroideremia Cone Dystrophy and 18 more

Localizaciones

Foundation Fighting Blindness, Columbia, Maryland, United States

A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)

Estado: Completado Categoria: Stargardt Resultado: Sin resultados

Patología

ENFERMEDAD DE STARGARDT

Tratamiento

Biological: hESC-RPE

Localizaciones

Moorefields Eye Hospital NHS Foundation Trust, London, United Kingdom Newcastle on Tyne NHS Foundation Trust, Newcastle upon Tyne, United Kingdom

Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)

Estado: Completado Categoria: Stargardt Resultado: Sin resultados

Patología

ENFERMEDAD DE STARGARDT

Tratamiento

Biological: MA09-hRPE

Localizaciones

Lothian Health Board Headquarters at Waverley Gate, Edinburgh, United Kingdom Moorefields Eye Hospital NHS Foundation Trust, London, United Kingdom Newcastle on Tyne NHS Foundation Trust, Newcastle upon Tyne, United Kingdom

Safety and Tolerability of MA09-hRPE Cells in Patients With Stargardt's Macular Dystrophy(SMD)

Estado: Estado desconocido Categoria: Stargardt Resultado: Sin resultados

Patología

ENFERMEDAD DE STARGARDT

Tratamiento

Biological: MA09-hRPE

Localizaciones

CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

DHA Supplementation in Patients With STGD3

Estado: Completado Categoria: Stargardt Resultado: Sin resultados

Patología

ENFERMEDAD DE STARGARDT HERENCIA DOMINANTE (STGD3)

Tratamiento

SUPLEMENTO DIETETICO: Over the counter DHA/EPA SUPLEMENTO DIETETICOation

Localizaciones

Moran Eye Center, University of Utah, Salt Lake City, Utah, United States

Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy

Estado: Completado Categoria: Stargardt Resultado: Sin resultados

Patología

Macular Dystrophy, Corneal

Tratamiento

MEDICAMENTO: 4-Methylpyrazole Other: saline

Localizaciones

Moran Eye Center, University of Utah, Salt Lake City, Utah, United States

Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy

Estado: Completado Categoria: Stargardt Resultado: Sin resultados

Patología

Macular Degeneration

Tratamiento

MEDICAMENTO: Docosahexaenoic Acid (DHA) SUPLEMENTO DIETETICO

Localizaciones

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Rod and Cone Mediated Function in Retinal Disease

Estado: Reclutando Categoria: Stargardt Resultado: Sin resultados

Patología

Retinal Degeneration Retinitis Pigmentosa ENFERMEDAD DE STARGARDT

Tratamiento

Device: Medmont Darl Adapted Chromatic (DAC) Device: RetMap, RM Electrode Device: MonCvONE electrophysiology

Localizaciones

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases

Estado: Estado desconocido Categoria: Stargardt Resultado: Sin resultados

Patología

Macular Degeneration ENFERMEDAD DE STARGARDT

Tratamiento

Procedure: Subretinal transplantation

Localizaciones

Southwest Hospital, Chongqing, Chongqing, China

Saffron Supplementation in Stargardt's Disease

Estado: Estado desconocido Categoria: Stargardt Resultado: Sin resultados

Patología

Retinal Degeneration Genetic Disease Single-Gene Defects Macular Dystrophy

Tratamiento

SUPLEMENTO DIETETICO: Saffron supplementation Other: placebo

Localizaciones

Policlinico A. Gemelli, Rome, Italy

Genotype-Phenotype Study of Patients With Plaquenil - Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene

Estado: Reclutando Categoria: Stargardt Resultado: Sin resultados

Patología

Genotype Retinal Disease

Localizaciones

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Study of STG-001 in Subjects With Stargardt Disease

Estado: Completado Categoria: Stargardt Resultado: Sin resultados

Patología

ENFERMEDAD DE STARGARDT-1

Tratamiento

MEDICAMENTO: STG-001

Localizaciones

Associated Retina Consultants, Phoenix, Arizona, United States Vitreo Retinal Associates, P.A., Gainesville, Florida, United States Casey Eye Institute - OHSU, Portland, Oregon, United States UPMC Eye Center, Pittsburgh, Pennsylvania, United States Retina Foundation of Southwest, Dallas, Texas, United States

A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies

Estado: Completado Categoria: Stargardt Resultado: Tiene resultados

Patología

ENFERMEDAD DE STARGARDT

Localizaciones

Greater Baltimore Medical Center, Baltimore, Maryland, United States Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, United States Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States Retina Foundation of the Southwest, Dallas, Texas, United States Moran Eye Center, University of Utah, Salt Lake City, Utah, United States Institut de la Vision, Paris, France Center for Ophthalmic Research, University of Teubingen, T bingen, Germany Moorfields Eye Hospital, London, United Kingdom

The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy

Estado: Completado Categoria: Stargardt Resultado: Sin resultados

Patología

ENFERMEDAD DE STARGARDT

Localizaciones

Wilmer Eye Institute, Baltimore, Maryland, United States Retina Foundation of the Southwest, Dallas, Texas, United States Universit ts-Augenklinik Bonn, Bonn, Germany Center for Opthalmic Research, University of Tuebingen, Tuebingen, Germany Moorfields Eye Hospital, London, United Kingdom

Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

Estado: Reclutando Categoria: Stargardt Resultado: Sin resultados

Patología

ENFERMEDAD DE STARGARDT 1

Tratamiento

MEDICAMENTO: Zimura Other: Sham

Localizaciones

Retinal Consultants of Arizona, Phoenix, Arizona, United States Jules Stein Eye Institute/ David Geffen School of Medicine, Los Angeles, California, United States VitreoRetinal Associates, Gainesville, Florida, United States Wilmer Eye Institute, Johns Hopkins, Baltimore, Maryland, United States Ophthalmic Consultants of Boston, Boston, Massachusetts, United States Kellogg Eye Center, Ann Arbor, Michigan, United States Retina Center P.A., Minneapolis, Minnesota, United States Oregon Health & Science University, Portland, Oregon, United States Mid Atlantic Retina, Philadelphia, Pennsylvania, United States UPMC Eye Center, Pittsburgh, Pennsylvania, United States and 30 more

Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration

Estado: Terminado Categoria: Stargardt Resultado: Tiene resultados

Patología

ENFERMEDAD DE STARGARDT

Tratamiento

MEDICAMENTO: SAR422459

Localizaciones

Investigational Site Number 840002, Miami, Florida, United States Investigational Site Number 840005, Iowa City, Iowa, United States Investigational Site Number 840001, Portland, Oregon, United States Investigational Site Number 840004, Houston, Texas, United States Investigational Site Number 250001, Paris, France

Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration

Estado: Activo, No reclutando Categoria: Stargardt Resultado: Sin resultados

Patología

ENFERMEDAD DE STARGARDT

Tratamiento

MEDICAMENTO: Long term follow up in all patients who received SAR422459 in previous study TDU13583

Localizaciones

Investigational Site Number 840001, Portland, Oregon, United States Investigational Site Number 250001, Paris, France

Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to ENFERMEDAD DE STARGARDT

Estado: Completado Categoria: Stargardt Resultado: Tiene resultados

Patología

ENFERMEDAD DE STARGARDT Macular Atrophy

Tratamiento

MEDICAMENTO: Emixustat

Localizaciones

Dallas, Texas, United States

Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and ENFERMEDAD DE STARGARDT

Estado: Completado Categoria: Stargardt Resultado: Sin resultados

Patología

Dry AMD ENFERMEDAD DE STARGARDT 1

Tratamiento

SUPLEMENTO DIETETICO: Madeos SUPLEMENTO DIETETICO: Placebo

Localizaciones

Centre National d'Ophtalmologie des Quinze-Vingts, Paris, France Department of Ophthalmology, Justus-Liebig-University- Giessen, Gie en, Germany Universit degli Studi G. d'Annunzio Chieti-Pescara, Chieti, Italy ASST Santi Paolo e Carlo, Milan, Italy Department of Ophthalmology, University Vita Salute, Milan, Italy

Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy

Estado: Reclutando Categoria: Stargardt Resultado: Sin resultados

Patología

ENFERMEDAD DE STARGARDT Diabetic Retinopathy DMAE

Tratamiento

Other: Anterior Chamber (AC) Tap

Localizaciones

Wilmer Eye Institute, Baltimore, Maryland, United States

Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

Estado: Inscripción por invitación Categoria: Stargardt Resultado: Sin resultados

Patología

ENFERMEDAD DE STARGARDT ENFERMEDAD DE STARGARDT ENFERMEDAD DE STARGARDT ENFERMEDAD DE STARGARDT 1 AUTOSOMICA RECESIVA ASOCIADA A ABCA4

Tratamiento

MEDICAMENTO: ALK-001

Localizaciones

Coordinating Center, Somerville, Massachusetts, United States

Phase 2 Tolerability and Effects of ALK-001 on ENFERMEDAD DE STARGARDT

Estado: Reclutando Categoria: Stargardt Resultado: Sin resultados

Patología

ENFERMEDAD DE STARGARDT ENFERMEDAD DE STARGARDT ENFERMEDAD DE STARGARDT ENFERMEDAD DE STARGARDT 1 , AUTOSOMICA RECESIVA RELACIONADA CON ABCA4

Tratamiento

MEDICAMENTO: ALK-001 MEDICAMENTO: Placebo

Localizaciones

University of California Los Angeles - Jules Stein Eye Institute, Los Angeles, California, United States Vitreoretinal Associates, Gainesville, Florida, United States University of Miami - Bascom Palmer Eye Institute, Miami, Florida, United States Johns Hopkins - Wilmer Eye Institute, Baltimore, Maryland, United States Columbia University Medical Center - Harkness Eye Institute, New York, New York, United States University of Utah - Moran Eye Institute, Salt Lake City, Utah, United States Medical College of Wisconsin - Eye Institute, Milwaukee, Wisconsin, United States

Sub-retinal Transplantation of hESC Derived RPE(MA09- hRPE)Cells in Patients With Stargardt's Macular Dystrophy

Estado: Completado Categoria: Stargardt Resultado: Sin resultados

Patología

ENFERMEDAD DE STARGARDT

Tratamiento

Biological: MA09-hRPE

Localizaciones

Jules Stein Eye Institute, UCLA School of Medicine, Los Angeles, California, United States Bascom Palmer Eye institute, Miami, Florida, United States Wills Eye Institute-Mid Atlantic Retina, Philadelphia, Pennsylvania, United States

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients

Estado: Completado Categoria: Stargardt Resultado: Sin resultados

Patología

ENFERMEDAD DE STARGARDT

Tratamiento

Biological: MA09-hRPE

Localizaciones

Jules Stein Eye Institute, UCLA School of Medicine, Los Angeles, California, United States Bascom Palmer Eye Institute, Miami, Florida, United States Wills Eye Institute-Mid Atlantic Retina, Philadelphia, Pennsylvania, United States

Safety and Efficacy of Emixustat in Stargardt Disease

Estado: Activo, No reclutando Categoria: Stargardt Resultado: Sin resultados

Patología

ENFERMEDAD DE STARGARDT

Tratamiento

MEDICAMENTO: Emixustat MEDICAMENTO: Placebo

Localizaciones

Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States UCSF Dept. of Ophthalmology, San Francisco, California, United States Emory University, Atlanta, Georgia, United States The Wilmer Eye Institute Johns Hopkins University, Baltimore, Maryland, United States University of Michigan Kellogg Eye Center, Ann Arbor, Michigan, United States Mayo Clinic Rochester, Rochester, Minnesota, United States Duke Eye Center, Durham, North Carolina, United States Casey Eye Institute - OHSU, Portland, Oregon, United States Retina Foundation of the Southwest, Dallas, Texas, United States University of Utah John Moran Eye Center, Salt Lake City, Utah, United States and 19 more

Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt Disease

Estado: Terminado Categoria: Stargardt Resultado: Sin resultados

Patología

ENFERMEDAD DE STARGARDT

Localizaciones

Kellogg Eye Center, Ann Arbor, Michigan, United States

Auditory Neural Function in Implanted Patients With Usher Syndrome

Estado: No reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Usher Syndrome Cochlear Implantation

Tratamiento

Other: Experimental manipulation of stimulation parameters

Localizaciones

Boston children's Hospital, Boston, Massachusetts, United States Gina Hounam, Columbus, Ohio, United States The Ohio State University, Columbus, Ohio, United States Vanderbilt University Medical Center, Nashville, Tennessee, United States

Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM)

Estado: No reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Ciliopathies Nephronophthisis Senior-Loken Syndrome Joubert Syndrome Jeune Syndrome Bardet-Biedl Syndrome

Tratamiento

Other: Blood sample Other: Urine sample

Localizaciones

H pital Necker-Enfants Malades, Paris, France

A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B

Estado: Activo no reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Usher's Syndrome

Tratamiento

Drug: Blood draw for the laboratory assessment

Localizaciones

Investigational Site Number 840001, Portland, Oregon, United States Investigational Site Number 250001, Paris, France

Stem Cell Ophthalmology Treatment Study

Estado: Inscripción por invitación Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Retinal Disease Macular Degeneration Hereditary Retinal Dystrophy Optic Nerve Disease Glaucoma

Tratamiento

Procedure: RB (Retrobulbar) Procedure: ST (Subtenon) Procedure: IV (Intravenous) Procedure: IVIT (Intravitreal) Procedure: IO (Intraocular)

Localizaciones

MD Stem Cells, Westport, Connecticut, United States

Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis

Estado: Activo no reclutando Categoria: Retinosis pigmentaria Resultado: Tiene resultados

Patología

Inherited Retinal Dystrophy Due to RPE65 Mutations Leber Congenital Amaurosis

Tratamiento

Biological: AAV2-hRPE65v2,voretigene neparvovec-rzyl

Localizaciones

University of Iowa, Iowa City, Iowa, United States Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Study of a Suprachoroidal Retinal Prosthesis

Estado: Inscripción por invitación Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Choroideremia

Tratamiento

Device: 44Ch Bionic Eye Device

Localizaciones

Centre for Eye Research Australia, Melbourne, Victoria, Australia

Rate of Progression in USH2A-related Retinal Degeneration

Estado: Activo no reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Usher Syndrome, Type 2A RETINOSIS PIGMENTARIA 39

Localizaciones

University of California, San Francisco, San Francisco, California, United States Vitreo-Retinal Associates, Gainesville, Florida, United States Wilmer Eye Institute at Johns Hopkins, Baltimore, Maryland, United States Massachusetts Eye and Ear, Boston, Massachusetts, United States Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, United States Duke University Eye Center, Durham, North Carolina, United States OHSU Casey Eye Institute, Portland, Oregon, United States Retina Foundation of the Southwest, Dallas, Texas, United States Baylor Eye Physicians and Surgeons, Houston, Texas, United States Moran Eye Center, University of Utah, Salt Lake City, Utah, United States and 6 more

Characterizing Rate of Progression in USHer Syndrome (CRUSH) Study

Estado: Activo no reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Usher Syndrome, Type 2A RETINOSIS PIGMENTARIA USH2A

Tratamiento

Other: No intervention

Localizaciones

Radboud universitair medisch centrum, Nijmegen, Gelderland, Netherlands

IRIS PILOT - Extended Pilot Study With a Retinal Implant System

Estado: Estado desconocido Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Cone-Rod Dystrophy Choroideremia

Tratamiento

Device: Retinal Implant System (IRIS)

Ver informe

Stem Cells Therapy in Degenerative Diseases of the Retina

Estado: Estado desconocido Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Retinal Degeneration RETINOSIS PIGMENTARIA Age Related Macular Degeneration Stargardt Disease 1

Tratamiento

Biological: Stem/progenitor cells transplantation

Localizaciones

I Department of Ophthalmology, Szczecin, Poland

Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy

Estado: Inscripción por invitación Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Non-exudative Age-related Macular Degeneration Diabetic Retinopathy Retina Vein Occlusion RETINOSIS PIGMENTARIA Hereditary Macular Degeneration

Tratamiento

Drug: CD34+ bone marrow stem cells intravitreal

Localizaciones

University of California Davis, Sacramento, California, United States

Advancing Understanding of Transportation Options

Estado: Activo no reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Diabetic Retinopathy Macular Degeneration Glaucoma RETINOSIS PIGMENTARIA Vision Disorders Acute Coronary Syndrome Implantable Defibrillator User Congestive Heart Failure Hypertrophic Obstructive Cardiomyopathy Orthostatic Hypotension and 22 more

Tratamiento

Behavioral: Driving Decision Aid Behavioral: Older Drivers Website

Localizaciones

University of California, San Diego, La Jolla, California, United States CU Anschutz Medical Center, Aurora, Colorado, United States Indiana University, Indianapolis, Indiana, United States

Long-term Follow-up Study in Subjects Who Received Voretigene Neparvovec-rzyl (AAV2-hRPE65v2)

Estado: Activo no reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Inherited Retinal Dystrophy Due to RPE65 Mutations

Tratamiento

Biological: AAV2-hRPE65v2

Ver informe

Clinical and Genetic Examination of Usher Syndrome Patients' Cohort in Europe

Estado: Estado desconocido Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Usher Syndrome

Localizaciones

CHU, Laboratoire de g n tique mol culaire, INSERM, Montpellier, France CIC of CHNO des Quinze-vingts, Paris, France Johannes Gutenberg University of Mainz, Institute of Zoology, Dept. Cell and Matrix Biology Mainz, Mainz, Germany Radboud University Nijmegen Medical Centre, Dept. Otorhinolaryngology, Nijmegen, Netherlands AIBILI, 4C - Coimbra Coordinating Centre for Clinical Research, Coimbra, Portugal IBILI- Faculty of Medicine - University of Coimbra, Center for Hereditary Diseases and Visual Neurosciences Laboratory, Coimbra, Portugal

A Patient Registry Study for Patients Treated With Voretigene Neparvovec in US

Estado: Activo no reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Confirmed Biallelic RPE65 Mutation- associated Retinal Dystrophy

Tratamiento

Biological: AAV2-hRPE65v2,voretigene neparvovec-rzyl

Localizaciones

Children's Hospital of Los Angeles, Los Angeles, California, United States Bascom Palmer Eye Institute, Miami, Florida, United States University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States Massachusetts Eye and Ear Institute, Boston, Massachusetts, United States Kellogg Eye Center, Ann Arbor, Michigan, United States Cincinnati Eye Institute, Cincinnati, Ohio, United States Casey Eye Institute, Portland, Oregon, United States Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, United States Scheie Eye Institute, Philadelphia, Pennsylvania, United States Cullen Eye Institute, Houston, Texas, United States

Object Finder for a Retinal Prosthesis

Estado: Activo no reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Device: Object recognition subsystem

Localizaciones

Johns Hopkins Hospital, Baltimore, Maryland, United States

Retinal Imaging of Subjects Implanted With Ciliary Neurotrophic Factor (CNTF)-Releasing Encapsulated Cell Implant for Early-stage Retinitis Pigmentosa

Estado: Estado desconocido Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Usher Syndrome Type 2 Usher Syndrome Type 3

Tratamiento

Drug: NT-501 Procedure: Sham

Localizaciones

University of California, San Francisco, San Francisco, California, United States

Prospective Open Clinical and Genetic Study of Patients With Retinitis Pigmentosa

Estado: Estado desconocido Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Usher Syndromes

Tratamiento

Diagnostic Test: Whole Exome Sequencing

Localizaciones

Federal State Budgetary Institution "Moscow Helmholtz Research Institute of Eye Diseases" of the Ministry of Health, Moscow, Russian Federation Central Clinical Hospital under President Affairs, Moscow, Russian Federation

Treatment of RP and LCA by Primary RPE Transplantation

Estado: Estado desconocido Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Leber Congenital Amaurosis, RETINOSIS PIGMENTARIA

Tratamiento

Biological: Human primary Retinal Pigment Epithelial (HuRPE) cells

Localizaciones

Beijing Tongren Hospital, Beijing, China

Argus II Retinal Stimulation System Feasibility Protocol

Estado: Estado desconocido Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Device: Argus II Retinal Stimulation System

Localizaciones

Doheny Eye Institute, Los Angeles, California, United States University of California San Francisco, San Francisco, California, United States Johns Hopkins, Wilmer Eye Institute, Baltimore, Maryland, United States Columbia University, Department of Ophthalmology, Edward S. Harkness Eye Institute, New York, New York, United States University of Pennsylvania, Scheie Eye Institute, Philadelphia, Pennsylvania, United States Wills Eye Hospital, Philadelphia, Pennsylvania, United States Retina Foundation of the Southwest, Dallas, Texas, United States Centre d'Investigation Clinique, Service d'Ophtalmologie, Quinze-Vingts National Eye Hospital, 28 rue de Charenton, 75557 Cedex 12, Paris, France Puerta de Hierro, Centro Medico, Centro de Retina, Zapopan, Jalisco, Mexico Clinique d'Ophthalmologie Hopitaux, Universitaires de Geneve 22 rue Alcide Jentzer 1205, Geneva, Switzerland Moorfields Eye Hospital, Vitreoretinal Research Unit, London, United Kingdom Manchester Royal Eye Hospital, Manchester, United Kingdom

Observational Study of the Argus II Retinal Prosthesis System

Estado: Estado desconocido Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Localizaciones

UHN Toronto Western Hospital 6E-438, Toronto, Ontario, Canada

New Enrollment Post-Approval Study of the Argus II Retinal Prosthesis System

Estado: Activo no reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Localizaciones

University of Southern California, Los Angeles, California, United States University of Colorado, Denver, Denver, Colorado, United States U. of Miami, Bascom Palmer Eye Institute, Miami, Florida, United States University of Miami Bascom Palmer Eye Institute, Miami, Florida, United States Emory University, Atlanta, Georgia, United States Retina Consultants of Hawaii, 'Aiea, Hawaii, United States University of Illinois at Chicago, Chicago, Illinois, United States Johns Hopkins, Lions Vision Center, Baltimore, Maryland, United States Tufts Medical Center, Boston, Massachusetts, United States University of Michigan, Kellogg Eye Center, Ann Arbor, Michigan, United States and 7 more

Efficacy and Safety of of vMCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]

Estado: No reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Retinitis Retinal Diseases Eye Diseases Eye Diseases, Hereditary Retinal Dystrophies Retinal Degeneration

Tratamiento

Biological: Gene Therapy Product- vMCO-010 Procedure: Sham Injection

Localizaciones

Nanoscope Clinical Site, Beverly Hills, California, United States Nanoscope Clinical Site, Miami, Florida, United States Nanoscope Clinical Site, Pensacola, Florida, United States Nanoscope Clinical Site, Fargo, North Dakota, United States Nanoscope Clinical Site, Houston, Texas, United States Nanoscope Clinical Site, McAllen, Texas, United States Nanoscope Clinical Site, Arecibo, Puerto Rico

Repository for Inherited Eye Diseases

Estado: Activo no reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Inherited Ophthalmic Diseases

Localizaciones

University of California, San Francisco, San Francisco, California, United States National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Self-confidence Study in Patients With Argus II Artificial Retina

Estado: Estado desconocido Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Pigmentary Retinopathy

Localizaciones

Service D'Ophtalmologie, Strasbourg, France

An Observational Study of Japanese Participants With X- linked Retinitis Pigmentosa

Estado: No reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

X-Linked RETINOSIS PIGMENTARIA

Localizaciones

National Hospital Organization Tokyo Medical Center, Tokyo, Japan

The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis Pigmentosa

Estado: No reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Dietary Supplement: Alga Dunaliella Bardawil powder Dietary Supplement: Placebo:Starch

Localizaciones

Goldschleger Eye Research Institute, Sheba Medical Center,, Tel Hashomer, Israel

A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations

Estado: No reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

X-Linked RETINOSIS PIGMENTARIA

Tratamiento

Biological: rAAV2tYF-GRK1-hRPGRco

Ver informe

Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) Retinitis Pigmentosa GTPase Regulator (RPGR)

Estado: Activo no reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

X-Linked RETINOSIS PIGMENTARIA

Tratamiento

Genetic: AAV2/5-RPGR

Localizaciones

Massachusetts Eye and Ear Institute, Boston, Massachusetts, United States Kellogg Eye Center, Ann Arbor, Michigan, United States UPMC Eye Center, Pittsburgh, Pennsylvania, United States Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom

Evaluation of the Visual Field on the Ground

Estado: No reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Syndrome

Tratamiento

Other: evaluation of the visual field on the ground

Ver informe

Aflibercept for Macular Oedema With Underlying RETINOSIS PIGMENTARIA (AMOUR) Study

Estado: Estado desconocido Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Macular Oedema RETINOSIS PIGMENTARIA

Tratamiento

Drug: Aflibercept

Localizaciones

Moorfields Eye Hospital, London, United Kingdom

Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pigmentosa

Estado: Activo no reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Biological: Stem Cell Transplantation

Localizaciones

Stem Cells Arabia, Amman, Jordan

Identifying Genes and Mutations Underlying RETINOSIS PIGMENTARIA and Allied Diseases

Estado: Estado desconocido Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Genetic: Genetic testing

Ver informe

FIGHT-RP 1 Extension Study

Estado: Activo no reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: NAC effervescent tablets

Localizaciones

Wilmer Eye Institute at Johns Hopkins University, Baltimore, Maryland, United States

Intravitreal Dexamethasone Implant in Retinitis Pigmentosa- related Macular Edema- a Retrospective Study

Estado: Estado desconocido Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Cystoid Macular Edema

Tratamiento

Device: dexamethasone injection

Ver informe

Autoimmunity in Retinitis Pigmentosa

Estado: Estado desconocido Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: twice-daily dosage with 0.5% cyclosporine-A eyedrops

Localizaciones

Semmelweis University, Dept. of Ophthalmology, Budapest, Hungary

Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa

Estado: Inscripción por invitación Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Choroideremia X-Linked RETINOSIS PIGMENTARIA

Tratamiento

Genetic: BIIB111 Genetic: BIIB112

Localizaciones

Research Site, Gainesville, Florida, United States Research Site, Miami, Florida, United States Research Site, Cincinnati, Ohio, United States Research Site, Portland, Oregon, United States Research Site, Dallas, Texas, United States Research Site, Madison, Wisconsin, United States Research Site, Edmonton, Alberta, Canada Research Site, Helsinki, Finland Research Site, Bonn, Germany Research Site, T bingen, Germany Research Site, Oxford, United Kingdom

Clinical Implication of Retinitis Pigmentosa Molecular Diagnostic Using High Throughput Sequencing.

Estado: Estado desconocido Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Localizaciones

Service d'Ophtalmologie CHU H pital G n ral, Dijon, France Service d'Ophtalmologie, H pital Robert Debr , CHR, Reims, France Affections Rares en G n tique Ophtalmologique (CARGO) H pital Civil, H pitaux Universitaires de Strasbourg, Strasbourg, France Service d'Ophtalmologie, CHU BRABOIS, Vandoeuvre Les Nancy, France

Studying a Potential Protective Effect of L-Dopa on RETINOSIS PIGMENTARIA

Estado: Estado desconocido Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: levodopa-carbidopa

Localizaciones

Beirut Eye Specialist Hospital, Beirut, Lebanon

Clinical Characterization on PDE6A-related RETINOSIS PIGMENTARIA in Preparation to a Gene Therapy Trial

Estado: Inscripción por invitación Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Localizaciones

Institute for Ophthalmic Research, University T bingen, Germany, T bingen, Baden-W rttemberg, Germany

Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of RETINOSIS PIGMENTARIA

Estado: No reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: Continuous oxygen Device: blue light-absorbing sunglasses Drug: Compound thrombosis capsule sig: 1.5g/tid Drug: Ginkgo biloba pills sig: 300mg/tid; Drug: Vitamin B sig: 10mg/tid Drug: Vitamin AD sig: 1 tablet/tid

Localizaciones

State Key Laboratory of Ophthalmology,Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China

Effects of Treatment With N- Acetylcysteine on Visual Outcomes in Patients With Retinitis Pigmentosa

Estado: Activo no reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: Prescribe N-acetylcysteine tablets Drug: Prescribe placebo tablets

Localizaciones

Ophthalmic Research Center, Tehran, Iran, Islamic Republic of

A New Treatment of Retinitis Pigmentosa

Estado: No reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Procedure: retrobulbar injection of autoserum Procedure: retrobulbar injection of placebo

Ver informe

Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With RETINOSIS PIGMENTARIA

Estado: Activo no reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Biological: human retinal progenitor cells

Localizaciones

Gavin Herbert Eye Inst, Univ Cal Irvine, Irvine, California, United States Retina-Vitreous Associates Medical Group, Los Angeles, California, United States Ophthalmic Consultants of Boston, Boston, Massachusetts, United States

Feasibility and Safety of Human Bone Marrow-derived Mesenchymal Stem Cells by Intravitreal Injection in Patients With Retinitis Pigmentosa

Estado: Estado desconocido Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Other: BM-MSC

Localizaciones

Siriraj Hospital Mahidol University, Bangkoknoi, Bangkok, Thailand

Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa

Estado: Activo no reclutando Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Device: Electro-acupuncture Device: Laser Acupuncture Device: Transcorneal Electrical Stimulation Device: Sham Electro-acupuncture Device: Sham laser acupuncture Device: Sham transcorneal electrical stimulation

Localizaciones

Nova Southeastern University; College of Optometry, Fort Lauderdale, Florida, United States

Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa

Estado: Estado desconocido Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Biological: BMMNCs

Localizaciones

Chaitanya Hospital, Pune,, Maharashtra, India

Retrospective Natural History Study of Retinitis Pigmentosa

Estado: Estado desconocido Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA (RP)

Localizaciones

CHNO XV-XX Paris - CIC 1423, Paris, France

RST-001 Phase I/II Trial for Advanced Retinitis Pigmentosa

Estado: Activo no reclutando Categoria: Retinosis pigmentaria Resultado: Tiene resultados

Patología

Advanced RETINOSIS PIGMENTARIA

Tratamiento

Drug: RST-001

Localizaciones

University of California, San Francisco- Dept. of Ophthalmology, San Francisco, California, United States Duke Eye Center, Durham, North Carolina, United States Cincinnati Eye Institute, Cincinnati, Ohio, United States Retina Foundation of the Southwest, Dallas, Texas, United States

Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: Tiene resultados

Patología

RETINOSIS PIGMENTARIA (RP)

Tratamiento

Biological: human retinal progenitor cells

Localizaciones

The Gavin Herbert Eye Institute, Univ California Irvine, Irvine, California, United States Retina-Vitreous Associates Medical Group, Los Angeles, California, United States

Study of SAR421869 in Participants With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: Tiene resultados

Patología

Usher Syndrome RETINOSIS PIGMENTARIA

Tratamiento

Drug: SAR421869

Localizaciones

Investigational Site Number 840001, Portland, Oregon, United States Investigational Site Number 250001, Paris, France

Rod Sensitivity in Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP)

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: Tiene resultados

Patología

RETINOSIS PIGMENTARIA AMD

Tratamiento

Diagnostic Test: Rod sensitivity

Localizaciones

Retina Foundation of the Southwest, Dallas, Texas, United States

A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: Tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: rhNGF 60 g/ml eye drops solution Drug: rhNGF 180 g/ml eye drops solution Drug: Placebo

Localizaciones

Azienda Ospedaliero Universitaria Careggi, Florence, Italy Azienda Ospedaliera San Paolo - U.O. Oculistica, Milano, Italy A.O. Seconda Universit Degli Studi di Napoli - Nuovo Policlinico - UOC Oftalmologia, Naples, Italy Universit Cattolica del Sacro Cuore - Policlinico Gemelli - Istituto di Oftalmologia, Rome, Italy IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia, Rome, Italy

An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: Tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: 400 g Brimonidine Tartrate Implant Drug: 200 g Brimonidine Tartrate Implant Drug: 100 g Brimonidine Tartrate Implant Other: Sham (no implant)

Localizaciones

Arlington, Texas, United States Paris, France Tubingen, Germany Coimbra, Portugal

Feasibility Study of a Chronic Retinal Stimulator in RETINOSIS PIGMENTARIA

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: Tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Device: Argus 16 Retinal Stimulation System

Localizaciones

Doheny Eye Institute, Los Angeles, California, United States

DHA and X-Linked Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: Tiene resultados

Patología

RETINOSIS PIGMENTARIA X-linked Genetic Diseases

Tratamiento

Drug: docosahexaenoic acid OR corn/soy oil placebo

Localizaciones

Retina Foundation of the Southwest, Dallas, Texas, United States

Evoked Retinal Response

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: Tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Procedure: Ultrasound Stimulus

Localizaciones

Columbia University Medical Center, New York, New York, United States

Computer-Assisted Rehabilitation Environment Training After Argus Retinal Prosthesis

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: Tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Device: CAREN system training

Localizaciones

Cleveland Clinic, Cleveland, Ohio, United States

Trial of Subretinal Injection of (rAAV2-VMD2-hMERTK)

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: Tiene resultados

Patología

Retinal Disease RETINOSIS PIGMENTARIA

Tratamiento

Biological: Subretinal administration of rAAV2-VMD2-hMERTKRecombinant Adeno-Associated Virus

Localizaciones

King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia

Collision Warning Device for Blind and Visually Impaired

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: Tiene resultados

Patología

Hemianopia Hemianopsia Peripheral Visual Field Defect Blindness RETINOSIS PIGMENTARIA Glaucoma

Tratamiento

Device: Collision warning device

Localizaciones

Schepens Eye Research Institute, Boston, Massachusetts, United States

Effect Of The System In The Enriched Fat Metabolism Of The Child Reached Mitochondrial Cytopathy

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Mitochondrial Cytopathies Disorders

Tratamiento

Other: high fat diet Other: normal fat diet

Localizaciones

Centre d'Investigation Clinique, Lille, France Centre d'Investigation Clinique, Paris, France

Nutritional Assessment in Mitochondrial Cytopathy

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Mitochondrial Diseases Mitochondrial Myopathies Mitochondrial Cytopathies

Localizaciones

Department of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital, Bern, Switzerland

Genetics and Clinical Characteristics of Bardet-Biedl Syndrome

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Bardet-Biedl Syndrome

Localizaciones

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT Alpha AMS

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Retinal Degeneration Inherited Retinal Dystrophy Primarily Involving Sensory Retina

Tratamiento

Device: RETINA IMPLANT Alpha AMS

Localizaciones

Clinique Saint Jean, Montpellier, H rault, France Centre Hospitalier Universitaire La Mil trie de Poitiers, Poitiers, Vienne, France

Gyrate Atrophy of the Choroid and Retina

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Gyrate Atrophy

Localizaciones

National Eye Institute (NEI), Bethesda, Maryland, United States

Cone Rescue in Retinitis Pigmentosa by the Treatment of Lycium Barbarum

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: Tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Dietary Supplement: Lycium Barbarum Dietary Supplement: Placebo

Localizaciones

The Hong Kong Polytechnic University, Hong Kong, Hong Kong

Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: Tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: Lutein Dietary Supplement: Cornstarch control

Localizaciones

Berman Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School ,Massachusetts Eye & Ear Infirmary, Boston, Massachusetts, United States

Trial of Oral Valproic Acid for Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: Tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: Valproic Acid Drug: Placebo

Localizaciones

University of Miami, Bascom Palmer Eye Institute, Miami, Florida, United States University of Michigan, Ann Arbor, Ann Arbor, Michigan, United States Oregon Health & Science University, Portland, Oregon, United States University of Tennessee, Hamilton Eye Institute, Memphis, Tennessee, United States Retina Foundation of the Southwest, Dallas, Texas, United States University of Utah School of Medicine, Moran Eye Center, Salt Lake City, Utah, United States

Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: Tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: Minocycline

Localizaciones

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Transcorneal Electrostimulation for Therapy of RETINOSIS PIGMENTARIA

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: Tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Device: Transcorneal electrostimulation

Localizaciones

Department f r Augenheilkunde, Eberhard-Karls-Universit t, T bingen, Germany

Visual Activity Evoked by Infrared in Humans After Dark Adaptation

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Age Related Macular Degeneration RETINOSIS PIGMENTARIA Congenital Stationary Night Blindness Colorblindness

Tratamiento

Other: Tungsten halogen light with narrow bandpass filters Other: ERG Other: VEP

Localizaciones

University of New Mexico, Albuquerque, New Mexico, United States

Potential Research Participants for Future Studies of Inherited Eye Diseases

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Cataract Glaucoma RETINOSIS PIGMENTARIA Macular Degeneration Strabismus

Localizaciones

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Bardet-Biedl Syndrome Orphan Diseases

Tratamiento

Behavioral: clinical, biological, and radiological

Localizaciones

H l ne Dollfus, Strasbourg, France

Transcorneal Electrical Stimulation Therapy for Retinal Disease

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Macula Off Primary Open Angle Glaucoma Hereditary Macular Degeneration Treated Retina Detachment Retinal Artery Occlusion Retinal Vein Occlusion Non-Arthritic-Anterior-Ischemic Optic- Neuropathy Hereditary Autosomal Dominant Optic Atrophy Dry Age Related Macular Degeneration Ischemic Macula Edema

Tratamiento

Device: Transcorneal Electrical Stimulation Device: DTL-electrode attached without energy

Ver informe

Gene Therapy for Blindness Caused by Choroideremia

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Choroideremia

Tratamiento

Drug: rAAV2.REP1

Localizaciones

Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom Oxford Radcliffe Hospitals NHS Trust, Oxford, United Kingdom Eye Unit, Southampton University Hospitals NHS Trust, Southampton, United Kingdom

Clinical Study of a Single Ciliopathy: Alstr m Syndrome

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Alstr m Syndrome (ALMS)

Localizaciones

CMCO, H pitaux Universitaires, Schiltigheim, France Centre d'Investigation Clinique, Nouvel H pital Civil, H pitaux Universitaires, Strasbourg, France Centre de R f rence pour les Affections Rares en G n tique Ophtalmologique (CARGO), H pitaux Universitaires, Strasbourg, France Clinique Psychiatrique, H pital Civil, H pitaux Universitaires, Strasbourg, France Service de Cardiologie, Nouvel H pital Civil, H pitaux Universitaires, Strasbourg, France Service de n phrologie et h modialyse, H pital Civil, H pitaux Universitaires, Strasbourg, France Service de physiologie et des Explorations Fonctionnelles, Nouvel H pital Civil, H pitaux Universitaires, Strasbourg, France Service de Psychoth rapie pour Enfants et Adolescents, H pital Civil, H pitaux Universitaires, Strasbourg, France Service d'Imagerie 1, H pital de Hautepierre, H pitaux Universitaires, Strasbourg, France Service d'ORL et de Chirurgie Cervico-Faciale, H pital de Hautepierre, H pitaux Universitaires, Strasbourg, France and 4 more

Vitamin Replacement in Abetalipoproteinemia

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Abetalipoproteinemia

Localizaciones

National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States

Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alstr m Syndrome (AS) Patients With Moderate to Severe Obesity

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Bardet Biedl Syndrome (BBS) Alstr m Syndrome (AS)

Tratamiento

Drug: Setmelanotide Drug: Placebos

Localizaciones

Wr-McCr, Llc, San Diego, California, United States UMMS Baystate Health; BAYSTATE MEDICAL CENTER; Baystate Children's Specialty Center, Springfield, Massachusetts, United States Columbia University Center, New York, New York, United States M3 Wake Research, Raleigh, North Carolina, United States University of Tennessee Health Science Center, Memphis, Tennessee, United States Marshfield Clinic Research Foundation, Marshfield, Wisconsin, United States Alberta Health Services, Edmonton, Alberta, Canada Sorbonne University Piti -Salp tri re Hospital, Paris, France H pital Civil, Strasbourg, France UPR Medical Sciences Campus, Rio Piedras, Puerto Rico Universidad Aut noma de Madrid University Hospital Ni o, Madrid, Spain St. Thomas Hospital, London, United Kingdom

Open-Label Rollover Study of PBI 4050 in Subjects With Alstr m Syndrome

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Alstr m Syndrome

Tratamiento

Drug: PBI-4050

Localizaciones

University Hospitals Birmingham NHS Foundation Trus, Birmingham, United Kingdom

Safety and Tolerability of PBI-4050 and Its Effects on the Biomarkers in Subjects With Alstr m Syndrome

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Inflammation and Fibrosis Diabetes

Tratamiento

Drug: PBI-4050

Localizaciones

University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

Argus II Retinal Prosthesis System Post-Market Surveillance Study

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Outer Retinal Degeneration RETINOSIS PIGMENTARIA

Localizaciones

Augenklinik des Staedtischen Klinikums, Karlsruhe, Baden- Wurttemberg, Germany Klinikum rechts der Isar - Technical University, Munich, Bavaria, Germany Center for Ophthalmology - University of Koln, Koln, NRW, Germany Knappschaftsklinikum Saar, Department of Ophthalmology, Sulzbach, Saarland, Germany University Medical Center Schleswig-Holstein, Department of Ophthalmology, L beck, Schleswig-Holstein, Germany RWTH University Eye Clinic, Aachen, Germany University Hospital Hamburg-Eppendorf, Klinik u. Poliklinik fur Augenheilkunde, Hamburg, Germany Universit tsklinikum Leipzig A R, Klinik und Poliklinik f r Augenheilkunde, Leipzig, Germany University of Pisa Eye Surgery Department, Pisa, Toscana, Italy ULSS 15 Alta Padovana Hospital, Camposampiero, Veneto, Italy

Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Retinal Diseases Eye Diseases Eye Disease, Hereditary Retinal Degeneration

Tratamiento

Drug: Valproic Acid

Localizaciones

Department of Ophthalmology, Seoul National University Hospital, Seoul, Korea, Republic of

Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Retinal Degeneration

Tratamiento

Device: Device name: "Retina Implant model Alpha". Surgical implantation of medical device into eye

Localizaciones

Helmut Sachs, MD, PD, Dresden, Germany Johann Roider, MD, Prof., Kiel, Germany Karl-Ulrich Bartz-Schmidt, MD, Prof., Tuebingen, Germany Miklos Resch, MD, PhD, Budapest, Hungary Timothy L Jackson, MB.ChB, PhD, FRCOphth, London, United Kingdom Robert MacLaren, MD, Prof., DPhil DipEd FRCOphth FRCS, Oxford, United Kingdom

Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Leber Congenital Amaurosis (LCA) RETINOSIS PIGMENTARIA (RP)

Tratamiento

Other: No treatment: retrospective chart review

Localizaciones

Wilmer Eye Institute - Johns Hopkins Hospital, Baltimore, Maryland, United States Casey Eye Institute - Marquam Hill, Portland, Oregon, United States The Hospital for Sick Children, Ophthalmology and Vision Sciences, Toronto, Ontario, Canada Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada Glostrup Hospital and National Eye Clinic at the Kennedy Center, Glostrup, Copenhagen, Denmark STZ Eyetrial at the Department of Ophthalmology - University of T bingen, T bingen, Germany Rotterdam Ophthalmic Institute, Rotterdam, Netherlands Jules Gonin Eye Hospital - Oculogenetic Unit, Lausanne, Switzerland Moorfields Eye Hospital - Research and Treatment Centre, London, United Kingdom

Microcurrent Stimulation to Treat Macular Degeneration

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Retinal Diseases Stargardt's Disease RETINOSIS PIGMENTARIA

Localizaciones

Hawaii Cataract Laser Institute - Hilo, Hilo, Hawaii, United States Retina Institute of Hawaii, Honolulu, Hawaii, United States Hawaii Cataract Laser Institute - Maui, Kahului, Hawaii, United States Hawaii Cataract Laser Institute - Kona, Kailua-Kona, Hawaii, United States

Pupil Dynamics and Color Vision for the Detection of Eye Diseases

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Leber's Hereditary Optic Neuropathy Stargardt Disease

Tratamiento

Behavioral: Dynamic pupillometry sessions

Localizaciones

Centre Hospitalier National D'Ophtal mologie des Quinze- Vingts, Paris, France

Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Cone Rod Dystrophy Choroideremia

Tratamiento

Device: Intelligent Retinal Implant System

Localizaciones

Medical University of Graz, Graz, Austria Clinique Ophtalmologique du CHU de Nantes, Nantes, France Hopital des Quinze Vingts/Fondation Ophtalmologique A. De Rothschild, Paris, France Dept. of Ophthalmology, University of Bonn, Bonn, Germany Klinik und Poliklinik f r Augenheilkunde Hamburg-Eppendorf, Hamburg, Germany

Clinical and Genetic Testing of Patients With Usher Syndrome

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Usher Syndrome Congenital Deafness RETINOSIS PIGMENTARIA

Localizaciones

Federal State Budgetary Institution "Research Center for Medical Genetics", Moscow, Russian Federation Deaf-Blind Support Foundation "Con-nection", Moscow, Russian Federation State Research Center Burnasyan Federal Medical Biophysical Center Federal Medical-Biological Agency, Moscow, Russian Federation Scientific and Clinical Center for Otorhinolaryngology of FMBA of Russia, Moscow, Russian Federation Oftalmic LLC, Moscow, Russian Federation Autonomous nonprofit organization "Scientific and industrial laboratory "Sensor technology for deafblind", Moscow, Russian Federation

Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Cone Rod Dystrophy Choroideremia

Tratamiento

Device: Intelligent Retinal Implant System

Localizaciones

Medical University of Graz, Graz, Austria Clinique Ophtalmologique du CHU de Nantes, Nantes, France CHU Nimes, Service Ophtalmologie (France)/ Hopital Gui de Chauliac, CHU Montpelier, (France), Nimes, France Hopital des Quinze Vingts/Fondation Ophtalmologique A. De Rothschild, Paris, France Dept. of Ophthalmology, University of Bonn, Bonn, Germany Universit ts KlinikumKlinik f r Augenheilkunde Freiburg, Freiburg, Germany Klinik und Poliklinik f r Augenheilkunde Hamburg -Eppendorf, Hamburg, Germany Instituto de Microcirugia Ocular, Barcelona, Spain Moorfields Eye Hospital, London, United Kingdom

A Genetic Analysis of Usher Syndrome in Ashkenazi Jews

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Usher Syndrome RETINOSIS PIGMENTARIA Congenital Hearing Impairment

Tratamiento

Procedure: Audiogram Procedure: Electroretinogram

Localizaciones

Mount Sinai School of Medicine, New York, New York, United States

Natural History and Genetic Studies of Usher Syndrome

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Syndromic Congenital Deafness Usher Syndrome RETINOSIS PIGMENTARIA and Deafness RETINOSIS PIGMENTARIA

Localizaciones

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States Queens College of the City University of New York, New York, New York, United States

Visual and Functional Assessment in Low Vision Patients

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Age-related Macular Degeneration Optic Nerve Pathology Inherited Retinal Dystrophies

Localizaciones

Oxford University Hospitals NHS Trust, Oxford, Oxfordshire, United Kingdom

Safety and Efficacy of the Alpha AMS Subretinal Implant

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Device: Implant 'on' vs implant 'off'

Localizaciones

Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom

Post-Market Study of the Argus II Retinal Prosthesis System - France

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Device: Argus II Retinal Prosthesis System

Localizaciones

Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France Centre hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris, France H pitaux Universitaires de Strasbourg, Strasbourg, France

Study of the Correlation Between Macular Thickness Analyzed by Optical Coherence Tomography and the Visual Functions in Retinitis Pigmemtosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Localizaciones

Naitonal Taiwan University Hospital, Taipei, Taiwan

Study of Dietary N-3 Fatty Acids in Patients With Retinitis Pigmentosa and Usher Syndrome

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Usher Syndrome RETINOSIS PIGMENTARIA

Localizaciones

Oregon Health Sciences University, Portland, Oregon, United States

Retina Implant Pilot Trial to Evaluate Safety & Efficacy in Blind Patients Having Degenerated Photo-receptors

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Device: Retina implant is surgically placed into subretinal position

Localizaciones

Eye Hospital Dresden-Friedrichstadt, Dresden, Germany University Eye Hospital Tuebingen, Tuebingen, Germany

Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal Diseases

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Device: SeeQ CdSe 655 ALT

Localizaciones

Asociacion Para Evitar La Ceguera En Mexico, I.A.P. (APEC), Mexico City, Mexico

Evaluation of Objective Perimetry Using Pupillometer

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Glaucoma Visual Field

Localizaciones

Sheba Medical Center, Tel Hashomer, Israel

Study of Usher Syndromes, Type 1 and Type 2

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Localizaciones

National Eye Institute (NEI), Bethesda, Maryland, United States

AUgmented REality for the Visually Impaired - Part 1

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Glaucoma

Tratamiento

Procedure: Find visual comfort threshold related to light intensity Procedure: Find the size of the visual field Procedure: Effectiveness of brightness control Procedure: Performance of color correction Device: Vuzix Wrap 1200DX virtural reality glasses

Localizaciones

CHRU de N mes - H pital Universitaire Car mea, N mes Cedex 09, France

Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Retinal Degeneration RETINOSIS PIGMENTARIA

Tratamiento

Procedure: surgical implantation of subretinal device

Localizaciones

Ophthalmology Eye Institute, University of Hong Kong, Hong Kong, Cyberport, Hong Kong

Effectiveness of a Cognitive-behavioral Program of Coping With Psychological Stress in People With Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Vision Disorders Stress, Psychological Psychopathy Self Efficacy

Tratamiento

Behavioral: A cognitive-behavioral intervention program Other: Standard intervention

Localizaciones

Jos Manuel P rez M rmol, Granada, Spain

Molecular Genetics of Retinal Degenerations

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Retinal Degeneration RETINOSIS PIGMENTARIA

Localizaciones

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States Harvard Medical School, Boston, Massachusetts, United States Cleveland Clinic Foundation Childrens Hospital, Cleveland, Ohio, United States Sun Yat-Sen University, Guangzhou, China Aravind Eye Hospital, Maduri, India University of Punjab, Lahore, Pakistan

Pilot Study of a Suprachoroidal Retinal Prosthesis

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Choroideremia

Tratamiento

Device: Prototype wide view suprachoroidal retinal prosthesis

Localizaciones

Nicta / Data61, Canberra, Australian Capital Territory, Australia Centre for Eye Research Australia, East Melbourne, Victoria, Australia

The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions im Patients With Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Dietary Supplement: Alga Dunaliella Bardawil Dietary Supplement: Alga Dunaliella Bardawill Other: Sugar pill

Localizaciones

Sheba Medical Center, Tel Hashomer, Israel

Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Cystoid Macular Edema

Tratamiento

Drug: rhNGF 180 g/ml eye drops solution Drug: vehicle eye drops

Localizaciones

Ospedale San Raffaele, Milan, Italy Ospedale Sacco, Milan, Italy

Transcorneal Electrical Stimulation - Multicenter Safety Study

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Device: Transcorneal electrostimulation

Localizaciones

Glostrup Hospital and Kennedy Center, Glostrup, Denmark University Eye Clinic Bonn, Bonn, Germany Augenzentrum M nchen, Munich, Germany University Eye Clinic Regensburg, Regensburg, Germany Zentrum f r seltene Netzhauterkrankungen, AugenZentrum Siegburg, Siegburg, Germany Centre for Ophthalmology at the eye clinic T bingen, T bingen, Germany Oslo University Hospital, Oslo, Norway

Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the Eye

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: Ciliary Neurotrophic Factor Implant NT-501

Localizaciones

National Eye Institute (NEI), Bethesda, Maryland, United States

Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravitreal vMCO-I in Patients With Advanced Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Retinal Diseases Retinal Degeneration

Tratamiento

Biological: Gene Therapy product:vMCO-I

Localizaciones

JPM Rotary Club of Cuttack Eye Hospital and Research Institute, Cuttack, Odisha, India

Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

LCA (Leber Congenital Amaurosis) RP (Retinitis Pigmentosa)

Tratamiento

Drug: QLT091001

Localizaciones

The Chicago Lighthouse (University of Illinois at Chicago, Pangere Center for Inherited Retinal Disease), Chicago, Illinois, United States Wilmer Eye Institute (Johns Hopkins University), Baltimore, Maryland, United States Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada Institute for Ophthalmic Research, University of Tubingen, Tubingen, Germany The Rotterdam Eye Hospital, Rotterdam, Netherlands Moorefield Eye Hospital, London, United Kingdom

Development of Visual Function Evaluation Method (2)

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Localizaciones

Site JP00001, Kobe, Hyogo, Japan

Development of Visual Function Evaluation Method

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Localizaciones

Site JP00001, Meguro-ku, Tokyo, Japan

Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

LCA (Leber Congenital Amaurosis) RP (Retinitis Pigmentosa)

Tratamiento

Drug: QLT091001

Localizaciones

The Chicago Lighthouse for People Who Are Blind or Visually Impaired (The Pangere Center For Inherited Retinal Diseases), Chicago, Illinois, United States Wilmer Eye Institute (Johns Hopkins University), Baltimore, Maryland, United States Scheie Eye Institute, Philadelphia, Pennsylvania, United States Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada Institute for Ophthalmic Research, University of Tubingen, Tubingen, Germany The Rotterdam Eye Hospital, Rotterdam, Netherlands Moorefield Eye Hospital, London, United Kingdom

The Role of Capsular Tension Ring (CTR) in Anterior Capsular Contraction

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Cataract

Tratamiento

Procedure: IOL surgery

Localizaciones

Aravind Eye Hospital, Madurai, Tamil Nadu, India

Effects of Lutein in Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: Lutein (10 or 30 mg/day) capsules

Localizaciones

Johns Hopkins Wilmer Eye Institute, Lions Vision Center, Baltimore, Maryland, United States

Randomized Trial for Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: Vitamin A Drug: Nutritional Supplement

Localizaciones

Berman-Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States

Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA (RP)

Tratamiento

Drug: QLT091001

Localizaciones

Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada Royal Victoria Eye and Ear Hospital, Dublin, Ireland

Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Inherited Retinal Dystrophy

Tratamiento

Biological: Wharton's jelly derived mesenchymal stem cell

Localizaciones

Ankara University Biotechnology Institute, Ankara, T rkiye, Turkey Umut Arslan, Ankara, T rkiye, Turkey

Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yellow Laser

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA Cystoid Macular Edema

Tratamiento

Device: SL-MPL treatment protocol was performed with a 577 nm yellow laser (EasyRet, Quantel Medical, Cedex, France)

Localizaciones

Ankara University Biotechnology Institute, Ankara, T rkiye, Turkey Umut Arslan, Ankara, T rkiye, Turkey

TES for the Treatment of RP

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Device: Transcorneal electrical stimulation

Localizaciones

Oxford University Hospitals NHS Trust, Oxford, Oxfordshire, United Kingdom Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom

Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: Vitamin E Drug: Vitamin A

Ver informe

Exercise and RP (AVAMC and Emory)

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Other: Spin exercise

Localizaciones

Emory Clinic, Atlanta VA Medical Center, Atlanta, Georgia, United States

The FIGHT-RP1 Study

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: N-Acetyl Cysteine (NAC)

Localizaciones

Wilmer Eye Institute, Johns Hopkins, Baltimore, Maryland, United States

Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: docosahexaenoic acid

Ver informe

A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

X-LinkedRETINOSIS PIGMENTARIA

Tratamiento

Biological: BIIB112

Localizaciones

Research Site, Gainesville, Florida, United States Research Site, Miami, Florida, United States Research Site, Portland, Oregon, United States Research Site, Philadelphia, Pennsylvania, United States Research Site, Dallas, Texas, United States Research Site, Manchester, United Kingdom Research Site, Oxford, United Kingdom Research Site, Southampton, United Kingdom

Stress and Vision Fluctuations in Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Localizaciones

Johns Hopkins WiImer Eye Insitute's Lions Vision Center, Baltimore, Maryland, United States

Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: UF-021 Drug: Placebo

Localizaciones

Nagoya, Aichi, Japan Hirosaki, Aomori, Japan Matsuyama, Ehime, Japan Maebashi, Gunma, Japan Kure, Hiroshima, Japan Sapporo, Hokkaido, Japan Kobe, Hyogo, Japan Mito, Ibaraki, Japan Morioka, Iwate, Japan Tsu, Mie, Japan and 24 more

A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: NT-501

Localizaciones

Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States University of Califoria, Davis, Sacramento, California, United States University of California, San Francisco, San Francisco, California, United States Retina Group of Florida, Hollywood, Florida, United States University of Florida, Jacksonville, Florida, United States Ophthalmic Consultants of Boston, Boston, Massachusetts, United States Kellogg Eye Center, Ann Arbor, Michigan, United States University of Minnesota, Minneapolis, Minnesota, United States NY University Medical Center, New York, New York, United States Casey Eye Institue, Portland, Oregon, United States and 3 more

A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: NT-501

Localizaciones

Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States University of Califoria, Davis, Sacramento, California, United States University of California, San Francisco, San Francisco, California, United States Bascom Palmer Eye Insitute, Miami, Florida, United States Ophthalmic Consultants of Boston, Boston, Massachusetts, United States Kellogg Eye Center, Ann Arbor, Michigan, United States University of Minnesota, Minneapolis, Minnesota, United States NY University Medical Center, New York, New York, United States Casey Eye Institue, Portland, Oregon, United States The Hamilton Eye Institute, Memphis, Tennessee, United States Retina Foundation of Southwest, Dallas, Texas, United States University of Utah, Salt Lake City, Utah, United States

A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: CNTO 2476

Localizaciones

Miami, Florida, United States Sw Portland, Oregon, United States Dallas, Texas, United States

Safety Study in Retinal Transplantation for Retinitis Pigmentosa.

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA.

Tratamiento

Device: Retinal transplantation instrument Device: Fetal tissue.

Localizaciones

Retina Vitreous Resource Center, Louisville, Kentucky, United States

Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: Vitamin A

Localizaciones

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Slowing the Degenerative Process, Long Lasting Effect of Hyperbaric Oxygen Therapy in Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Procedure: hyperbaric oxygen therapy

Localizaciones

Azienda Policlinico Umberto I, Rome, Italy

Autosomal Dominant Retinitis Pigmentosa: Prevalence of Known Genes Identification of New Loci / Genes

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

Autosomal DominantRETINOSIS PIGMENTARIA

Tratamiento

Genetic: genetic analysis

Localizaciones

CHRU Montpellier, Montpellier, France

Acupuncture for the Treatment of Vision Loss Due to Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Procedure: Electro-acupuncture

Localizaciones

Johns Hopkins University, Baltimore, Maryland, United States

Effects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Biological: Platelet rich plasma

Localizaciones

Ankara University Biotechnology Institute, Ankara, T rkiye, Turkey

Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Combination Product: PRP combined Magnovision Biological: PRP

Ver informe

Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Biological: Umbilical Cord Mesenchymal Stem Cell (UC-MSC) Biological: Conditioned Medium (CM)

Localizaciones

Jakarta Eye Center Hospital, Jakarta, DKI Jakarta, Indonesia Sardjito Hospital, Yogyakarta, Special Region, Indonesia

Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Biological: intravitreal injection of autologous bone marrow stem cells

Localizaciones

Centro de Pesquisa Rubens Siqueira, Sao Jose do Rio Preto, SP, Brazil

Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Biological: intravitreal injection of autologous bone marrow stem cells

Localizaciones

CPRS, S o Jose do Rio Preto, SP, Brazil

Biomarkers In Retinitis Pigmentosa (BIRP)

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Other: Anterior Chamber (AC) tap

Localizaciones

Wilmer Eye Institute, Baltimore, Maryland, United States

Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Biological: human retinal progenitor cells Other: Mock injection

Localizaciones

Gavin Herbert Eye Inst, Univ Cal Irvine, Irvine, California, United States Retina-Vitreous Associates Medical Group, Los Angeles, California, United States Ophthalmic Consultants of Boston, Boston, Massachusetts, United States

Observational Natural History Study of Autosomal Dominant Retinitis Pigmentosa (adRP)

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Diagnostic Test: Observation

Localizaciones

Texas Retina Associates,, Dallas, Texas, United States

Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa

Estado: Terminado Categoria: Retinosis pigmentaria Resultado: No tiene resultados

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Biological: Intravitreal injection of Autologous bone marrow Stem Cell Other: Subconjunctival injection of saline

Localizaciones

Clinical Universitary Hospital Virgen de la Arrixaca, El Palmar, Murcia, Spain

High Resolution Retina Imaging

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA Maculopathy, Age Related Macular Dystrophy Macular Edema Retinal Degeneration Diabetic Retinopathy Occlusion Retinal Vein Hypertension

Localizaciones

H pital Lariboisi re, Paris, France Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris, France H pital Piti -Salp tri re, Paris, France

Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Diabetic Retinopathy Retinal Vein Occlusion Retinal Artery Occlusion Central Serous Chorioretinopathy Pathologic Myopia RETINOSIS PIGMENTARIA Epiretinal Membrane Macular Holes Nonexudative Age-related Macular Degeneration Exudative Age Related Macular Degeneration and 3 more

Tratamiento

Diagnostic Test: Software assisted imaging diagnosis

Localizaciones

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, BeiJing, Beijing, China The Second Hospital of Hebei Medical University, Shijia Zhuang, Hebei, China West China Hospital of Sichuan University, Chengdu, Sichuan, China Tianjin Medical University Eye Hospital, Tianjin, Tianjin, China Eye Hospital, WMU Zhejiang Eye Hospital, Wenzhou, Zhejiang, China

Natural History Study of Usher Syndrome ( Light4Deaf )

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Usher Syndromes

Localizaciones

Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris, France CHU Piti Salp tri re, Paris, France CHU Necker, Paris, France CHU Robert Debr , Paris, France

GROWing Up With Rare GENEtic Syndromes

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Prader-Willi Syndrome PWS-like Syndrome Silver Russel Syndrome Congenital Hypopituitarism Klinefelter (XXY-)Syndrome Congenital Adrenal Hyperplasia XXXXY Syndrome XXYY Syndrome XXXX Syndrome (Tetra-X Syndrome) Disorders of Sex Development and 23 more

Tratamiento

Diagnostic Test: Retrospective file studies

Localizaciones

Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands

COhort for Bardet-Bield Syndrome and Alstr m Syndrome for Translational Research Monocentric Interventional Study

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Bardet-Biedl Syndrome Alstr m Syndrome

Tratamiento

Genetic: Skin biopsy

Localizaciones

Les H pitaux Universitaires de Strasbourg, Strasbourg, France

Natural History Study in Subjects With Usher Syndrome

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Usher Syndrome, Type 1B

Localizaciones

Eye Clinic of the University of Campania Luigi Vanvitelli, Naples, Italy Stichting Oogziekenhuis Rotterdam, Rotterdam, Netherlands Instituto de Investigacion Sanitaria de la Fundacion Jimenez Diaz, Madrid, Spain

Clinical Registry Investigating Bardet-Biedl Syndrome

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Bardet-Biedl Syndrome

Localizaciones

Marshfield Clinic Research Foundation, Marshfield, Wisconsin, United States

UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Hepato/Renal Fibrocystic Disease Autosomal Recessive Polycystic Kidney Disease Joubert Syndrome Bardet Biedl Syndrome Meckel-Gruber Syndrome Congenital Hepatic Fibrosis Caroli Syndrome Oro-Facial-Digital Syndrome Type I Nephronophthisis Glomerulocystic Kidney Disease

Localizaciones

Children's National Health System, Washington, District of Columbia, United States

Development of iPS From Donated Somatic Cells of Patients With Neurological Diseases

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Neurodegenerative Disorders

Localizaciones

Hadassah Ein Kerem, Jerusalem, Israel

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Mitochondrial Disorders Mitochondrial Genetic Disorders Mitochondrial Diseases Disorder of Mitochondrial Respiratory Chain Complexes Deletion and Duplication of Mitochondrial DNA

Localizaciones

University of California San Diego, San Diego, California, United States Lucile Packard Children's Hospital, Stanford, California, United States Children's Hospital of Colorado, Aurora, Colorado, United States Children's National Medical Center, Washington, District of Columbia, United States University of Florida, Gainesville, Florida, United States Massachusetts General Hospital, Boston, Massachusetts, United States Mayo Clinic, Rochester, Minnesota, United States Columbia University Medical Center, New York, New York, United States Virtual Site (Remote enrollment), New York, New York, United States Akron Children's Hospital, Akron, Ohio, United States and 7 more

Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Retinal Degeneration RETINOSIS PIGMENTARIA Eye Diseases, Hereditary

Localizaciones

University of California, San Francisco, San Francisco, California, United States The Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland, United States Hospital for Sick Children, Toronto, Ontario, Canada University of Tubingen, T bingen, Germany Haddassah Medical Center, Jerusalem, Israel Radboud University, Nijmegen, Netherlands

Cell Collection to Study Eye Diseases

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Retinal Disease AMD Retinal Degeneration RETINOSIS PIGMENTARIA

Localizaciones

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

High Resolution Retinal Imaging

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Stargardts RETINOSIS PIGMENTARIA Age-related Macular Degeneration Choroideremia Geographic Atrophy

Tratamiento

Procedure: Retinal imaging

Localizaciones

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Sildenafil for Treatment of Choroidal Ischemia

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Choroidal Ischemia Vitelliform Macular Dystrophy Age-related Macular Degeneration Central Serous Retinopathy RETINOSIS PIGMENTARIA

Tratamiento

Drug: Sildenafil Other: Standard of Care Sildenafil Diagnostic Test: Ocular Coherence Tomography-Angiography (OCT-A) Other: Visual Acuity (VA)

Localizaciones

Columbia University Medical Center, Edward Harkness Eye Institute, New York, New York, United States

Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Low Vision RETINOSIS PIGMENTARIA Stargardt Disease 1 Stargardt Disease 3 Stargardt Disease 4 Albinism

Tratamiento

Device: Virtual Reality Headset based tests

Localizaciones

NI Clinical Research Facility, Belfast, Northern Ireland, United Kingdom

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Rare Disorders Undiagnosed Disorders Disorders of Unknown Prevalence Cornelia De Lange Syndrome Prenatal Benign Hypophosphatasia Perinatal Lethal Hypophosphatasia Odontohypophosphatasia Adult Hypophosphatasia Childhood-onset Hypophosphatasia Infantile Hypophosphatasia and 286 more

Localizaciones

Sanford Health, Sioux Falls, South Dakota, United States Online Patient Enrollment System, Sydney, Australia

Stem Cell Ophthalmology Treatment Study II

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Retinal Disease Age-Related Macular Degeneration RETINOSIS PIGMENTARIA Stargardt Disease Optic Neuropathy Nonarteritic Ischemic Optic Neuropathy Optic Atrophy Optic Nerve Disease Glaucoma Leber Hereditary Optic Neuropathy and 8 more

Tratamiento

Procedure: Arm 1 Procedure: Arm 2 Procedure: Arm 3

Localizaciones

MD Stem Cells, Westport, Connecticut, United States MD Stem Cells, Coral Springs, Florida, United States Fakeeh University Hospital, Dubai, United Arab Emirates

Inherited Retinal Degenerative Disease Registry

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Eye Diseases Hereditary Retinal Disease Achromatopsia Bardet-Biedl Syndrome Bassen-Kornzweig Syndrome Batten Disease Best Disease Choroidal Dystrophy Choroideremia Cone Dystrophy and 18 more

Localizaciones

Foundation Fighting Blindness, Columbia, Maryland, United States

Bimodal and Coaxial High Resolution Ophtalmic Imaging

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA Maculopathy, Age Related Macular Dystrophy Macular Edema Retinal Detachment Retinal Degeneration Glaucoma Vascular Inflammation Hypertension Stroke Diabetes

Tratamiento

Other: Bimodal high resolution imaging of the retina

Localizaciones

Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris, France

Multimodal Ophthalmic Imaging

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA Maculopathy, Age Related Macular Dystrophy Macular Edema Retinal Detachment Retinal Degeneration Glaucoma Vascular Inflammation Hypertension Stroke and 5 more

Tratamiento

Device: High-resolution retinal imaging through adaptive optics Device: High-resolution retinal imaging through holographic systems

Localizaciones

Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris, France

Impact of Visual Field Restriction on Visual Exploration

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Pigmentary Retinopathy

Tratamiento

Other: Eye tracker

Localizaciones

Institut de la vision, Paris, France

A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Autosomal Dominant RETINOSIS PIGMENTARIA Eye Diseases Eye Diseases, Hereditary Retinal Dystrophies Retinal Disease Retinitis Vision Tunnel Vision Disorders

Tratamiento

Drug: QR-1123 Other: Sham procedure

Localizaciones

Sue Anschutz-Rogers Eye Center, University of Colorado - Dept. of Ophthalmology, Aurora, Colorado, United States VitreoRetinal Associates, Gainesville, Florida, United States Shriners UK Ophthalmology - University of Kentucky, Lexington, Kentucky, United States Casey Eye Institute, OHSU, Portland, Oregon, United States Retina Foundation of the Southwest, Dallas, Texas, United States

NR600 System Retinal Prosthesis for Patients With Retinal Degenerative Diseases

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA Retinal Degeneration

Tratamiento

Device: Retinal surgery with implantation of epi-retinal device

Localizaciones

UZ Ghent, Ghent, Belgium UZ Leuven, Leuven, Belgium Rabin Medical Center, Petach Tikva, Israel Sourasky Medical Center, Tel AViv, Israel San Raffaele, Milan, Italy Fondazione Policlinico A. Gemelli, IRCCS, Rome, Italy

Phenotype Correlates Genotype of Inherited Retina Dystrophies, Retinitis Pigmentosa, Con>Rod Dystrophies.

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA Cone Dystrophy Usher Syndromes Retina; Dystrophy

Tratamiento

Diagnostic Test: Retina Analysis-mosaic Diagnostic Test: Autofluorescence Diagnostic Test: OCT- 1 micra Procedure: Genotype analysis

Localizaciones

Retina and Genomics Institute, Merida, Yucatan, Mexico

Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Usher Syndromes

Tratamiento

Drug: NPI-001 Other: Placebo

Localizaciones

Queensland Eye Institute, Brisbane, Australia CERA, Melbourne, Australia Lions Eye Institute, Perth, Australia Sydney Eye Hospital / Save Sight Institute, Sydney, Australia

Natural History of Patients With Inherited Retinal Diseases Due to Mutations in RPE65 Gene

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Leber Congenital Amaurosis 2 RETINOSIS PIGMENTARIA 20

Localizaciones

Ospedale di Camposampiero, ULSS6 Euganea, Camposampiero, Camposampiero, Italy UOC Oculistica - AOU Careggi, Florence, Italy UOC Oculistica - Ospedale Sacco, Milan, Italy UOC Oculistica - Ospedale San Paolo, Milan, Italy UOC Oculistica - AOU Universit degli Studi della Campania Luigi Vanvitelli, Naples, Italy Centro di Neuroftalmologia dell'et evolutiva - IRCCS Fondazione Istituto Neurologico Nazionale C. Mondino, Pavia, Italy UOC Oculistica - Fondazione IRCCS Policlinico San Matteo, Pavia, Italy UOC Oculistica - Ospedale Bambin Ges di Roma, Rome, Italy UOC Oculistica - Policlinico Gemelli di Roma, Rome, Italy

Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Retinal Dystrophies RETINOSIS PIGMENTARIA Glaucoma

Localizaciones

Sheba Medical Center, Tel HaShomer, Israel

Rod and Cone Mediated Function in Retinal Disease

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Retinal Degeneration RETINOSIS PIGMENTARIA Stargardt's Disease

Tratamiento

Device: Medmont Darl Adapted Chromatic (DAC) Device: RetMap, RM Electrode Device: MonCvONE electrophysiology

Localizaciones

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Environmental Localization Mapping and Guidance for Visual Prosthesis Users

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA Visual Impairment Visual Prosthesis

Tratamiento

Device: Navigation System for Users of a Visual Prosthesis

Localizaciones

Johns Hopkins Medicine - Wilmer Eye Institute, Baltimore, Maryland, United States Johns Hopkins Applied Physics Laboratory, Laurel, Maryland, United States

Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA Usher Syndrome Type 2 Deaf Blind Retinal Disease Eye Diseases Eye Diseases, Hereditary Eye Disorders Congenital Vision Disorders

Tratamiento

Drug: QR-421a Other: Sham-procedure (dose cohort 1&2 only)

Localizaciones

Center for Clinical Research Operations, Massachusetts Eye and Ear, Boston, Massachusetts, United States University of Michigan, Kellogg Eye Center, Ann Arbor, Michigan, United States Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States Retina Foundation of the Southwest, Dallas, Texas, United States UZ Gent, Department Ophthalmology, Gent, Belgium Centre for Innovative Medicine, Department of Paediatric Surgery, Montreal Children's Hospital at the McGill University Health Centre, Montr al, Canada H pital Gui de Chauliac - CHRU de Montpellier - Maladies Sensorielles G n tique, Montpellier, France Centre de maladies rares CHNO des Quinze Vingts, Paris, France

Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Biological: Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE)

Localizaciones

Centre Hospitalier National d'Ophtalmologie (CHNO) des Quinze-Vingts, Paris, France

Minocycline Treatment in Retinitis Pigmentosa

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA Inherited Retinal Dystrophy Retina Disorder

Tratamiento

Drug: Minocycline

Localizaciones

Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China

The Effect of Oral Administration of 9-cis # Carotene Rich Powder of the Alga Dunaliella Bardawil

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Dietary Supplement: Alga Dunaliella Bardawil Other: Placebo (starch)

Localizaciones

Sheba Medical Center, Tel Hashomer, Israel

Long Term Follow-Up Gene Therapy Study for XLRP RPGR

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

X-Linked RETINOSIS PIGMENTARIA

Tratamiento

Biological: AAV-RPGR

Localizaciones

Moorfields Eye Hospital, London, United Kingdom

The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA Retinal Degeneration Cannabis

Tratamiento

Drug: cannabis

Localizaciones

Hadassah Medical Center, Jerusalem, Israel

Validation of Standardized Test Protocols to Assess the Impact of Visual Pathologies in Daily Life Activities

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Behavioral: performance of behavioral locomotion tasks phase 1 Behavioral: performance of behavioral locomotion tasks phase 2

Localizaciones

Centre hospitalier national d'ophtalmologique de 15-20, Paris, France

Experimental and Clinical Studies of Retinal Stimulation

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Device: New visual processing unit (VPU) with asymmetric waveforms Device: New VPU with bipolar stimulation

Localizaciones

University of Michigan, Ann Arbor, Michigan, United States

Argus II/ORCAM Device Study

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Device: Argus II Eyeglasses Device: ORCAM

Localizaciones

Mayo Clinic in Rochester, Rochester, Minnesota, United States

Retinal Imaging in Patients With Inherited Retinal Degenerations

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Localizaciones

Department of Ophthalmology Retinal Degenerations Clinic, UCSF, San Francisco, California, United States

Rate of Progression in EYS Related Retinal Degeneration

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA Eye Diseases

Localizaciones

Associated Retina Consultants, Phoenix, Arizona, United States Stanford Department of Ophthalmology, Palo Alto, California, United States University of California-San Diego: Shirley Eye Institute, San Diego, California, United States University of California, San Francisco, San Francisco, California, United States Colorado Retina Associates, Denver, Colorado, United States National Eye Institute (NEI), Washington, District of Columbia, United States Vitreo-Retinal Associates, Gainesville, Florida, United States University of Miami: Neuro-ophthalmology Department, Miami, Florida, United States Emory Eye Center, Atlanta, Georgia, United States University of Kentucky, Lexington, Kentucky, United States and 17 more

Mobility Protocol Adapted for Advanced Visually Impaired Subjects

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Pigmentary Retinopathy

Tratamiento

Behavioral: Locomotion task Behavioral: Posturology task SOT (Sensory Organization Test) Behavioral: The quality of life questionnaire

Localizaciones

Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris, France

4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

X-Linked RETINOSIS PIGMENTARIA

Tratamiento

Biological: 4D-125 IVT Injection Other: Observational

Localizaciones

University of Colorado, Aurora, Colorado, United States University of Michigan Kellogg Eye Center, Ann Arbor, Michigan, United States Duke University Eye Center/Dept. of Ophthalmology, Durham, North Carolina, United States Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, United States Retina Foundation of the Southwest, Dallas, Texas, United States University of Utah John A. Moran Eye Center, Salt Lake City, Utah, United States

Gene Therapy Trial for the Treatment of X-linked RETINOSIS PIGMENTARIA Associated With Variants in the RPGR Gene

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

X-Linked RETINOSIS PIGMENTARIA

Tratamiento

Biological: Genetic: AAV5-RPGR

Localizaciones

Vitreol Retinal Associates, Gainesville, Florida, United States The Emory Eye Centre, Atlanta, Georgia, United States Massachusetts Eye and Ear, Centre for Clinical Research Operations, Boston, Massachusetts, United States University of Michigan, Ann Arbor, Michigan, United States Retinal Consultants of Houston, Bellaire, Texas, United States

Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

X-Linked RETINOSIS PIGMENTARIA

Tratamiento

Biological: Genetic: AAV5-RPGR 4e11 Biological: Genetic: AAV5-RPGR 2e11

Localizaciones

Vitreo Retinal Associates, Gainesville, Florida, United States The Emory Eye Centre, Atlanta, Georgia, United States Boston Eye and Ear, Boston, Massachusetts, United States Univeristy of Michigan, Ann Arbor, Michigan, United States Retinal Consultants of Houston, Bellaire, Texas, United States

Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

Non-syndromic RETINOSIS PIGMENTARIA

Tratamiento

Combination Product: Gene therapy: GS030-DP AND Medical device: GS030- MD

Localizaciones

UPMC Eye Center, Pittsburgh, Pennsylvania, United States Centre Hospitalier National d'Ophtalmologie (CHNP) des Quinze-Vingts, Paris, France Moorfields Eye Hospital NHS Foundation Trust, 162 City Road, London, United Kingdom

Clinical Evaluation of Patients With X-linked RETINOSIS PIGMENTARIA (XLRP)

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

X-Linked RETINOSIS PIGMENTARIA

Localizaciones

Duke Eye Center, Duke University Medical Center, Durham, North Carolina, United States Casey Eye Institute, Oregon Health and Sciences University, Portland, Oregon, United States Retina Foundation of the Southwest, Dallas, Texas, United States

Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR)

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Localizaciones

Shiley Eye Institute - UCSD, La Jolla, California, United States Emory Eye Centre, Atlanta, Georgia, United States Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States Kellogg Eye Center, Ann Arbor, Michigan, United States UPMC Eye Centre, Pittsburgh, Pennsylvania, United States The Hospital for Sick Children, Toronto, Canada Moorfields Eye Hospital, London, United Kingdom

Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

X-Linked RETINOSIS PIGMENTARIA

Tratamiento

Biological: rAAV2tYF-GRK1-RPGR

Localizaciones

University of Florida, Jacksonville, Florida, United States Boston Children's Hospital, Boston, Massachusetts, United States Columbia University, New York, New York, United States Duke Eye Center, Durham, North Carolina, United States Cincinnati Eye Institute, Cincinnati, Ohio, United States Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, United States Retina Foundation of the Southwest, Dallas, Texas, United States

CNS10-NPC for the Treatment of RP

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Biological: CNS10-NPC implantation

Localizaciones

Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States

CNGB1 and Allied Disorders

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA Associated With CNGB1 Mutations

Tratamiento

Other: No intervention, this is a natural history progression study

Localizaciones

Dr. Stephen H. Tsang, New York, New York, United States Wills Eye Hospital, Philadelphia, Pennsylvania, United States Institut de la Vision/Centre de maladies rares du Centre Hospitalier National Ophtalmologique des Quinze-Vingts, Paris, France Klinikum der Universit t M nchen University Eye Hospital, Ludwig-Maximilians-University (LMU) Munich, M nchen, Bavaria, Germany Eberhard Karls University Tubingen, Tuebingen, Germany Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom

Prospective Natural History Study of Retinitis Pigmentosa

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Other: Ophthalmic examination Other: Mobility Test

Localizaciones

CHNO XV-XX Paris - CIC 1423, Paris, France

BS01 in Patients With Retinitis Pigmentosa

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: BS01

Localizaciones

OCLI, New York, New York, United States

A Natural History Study to Evaluate Functional and Anatomical Progression in Retinitis Pigmentosa

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Localizaciones

Wilmer Eye Institute at Johns Hopkins University, Baltimore, Maryland, United States

Retinitis Pigmentosa Clinical Measures and Repeatability Testing of Potential Outcome Measures

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Device: RetMAP RM electrode Device: RetiMap Multifocal ERG Device: rtx1 Adaptive Optics camera

Localizaciones

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Safety and Efficacy Study in Patients With RETINOSIS PIGMENTARIA Due to Mutations in PDE6B Gene

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Biological: AAV2/5-hPDE6B

Localizaciones

Clinique Ophtalmologique, CHU de Nantes, Nantes, France

Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: Hydroxychloroquine lower dose Drug: Hydroxychloroquine higher dose

Localizaciones

University of Michigan, Ann Arbor, Michigan, United States

Natural History Study of Retinitis Pigmentosa Type 11

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA 11 RETINOSIS PIGMENTARIA

Tratamiento

Diagnostic Test: Clinical examinations

Localizaciones

Department of Ophthalmology, Oslo University Hospital, Oslo, Norway

Safety and Efficacy of Subretinal Transplantation of Clinical Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Retinitis Pigmentosa

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Biological: Retinal pigment epitheliums transplantation

Localizaciones

Beijing Tongren Hospitol,Capital Medical University, Beijing, Beijing, China

Safety and Tolerability of hRPC in Retinitis Pigmentosa

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: hRPC

Localizaciones

Retinal Research Institute, Phoenix, Arizona, United States Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States Oregon Health and Science University, Portland, Oregon, United States Institut de la M cula, Barcelona, Spain Oxford Eye Hospital, Oxford, United Kingdom

Natural History of the Progression of X-Linked RETINOSIS PIGMENTARIA

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

X-Linked RETINOSIS PIGMENTARIA

Tratamiento

Other: Other: Assessments

Localizaciones

Research Site, Phoenix, Arizona, United States Research Site, Los Angeles, California, United States Research Site, San Francisco, California, United States Research Site, Miami, Florida, United States Research Site, New York, New York, United States Research Site, Portland, Oregon, United States Research Site, Dallas, Texas, United States Research Site, Houston, Texas, United States Research Site, Salt Lake City, Utah, United States Research Site, Madison, Wisconsin, United States and 12 more

CB-PRP in Retinitis Pigmentosa

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Biological: Subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP)

Localizaciones

Alfonso Savastano, Rome, Italy

A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Biological: CPK850

Localizaciones

Novartis Investigative Site, Stockholm, Sweden

Pilot Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis Pigmentosa

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Biological: Intravitreal autologous CD34+ cells

Localizaciones

University of California Davis, Sacramento, California, United States

Investigation of Therapeutic Efficacy and Safety of UMSCs for the Management of Retinitis Pigmentosa (RP)

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA (RP)

Tratamiento

Biological: Injection of stem cells in sub- tenon space of eye for the management of RETINOSIS PIGMENTARIA Biological: Injection of stem cells in suprachoroidal space of eye for the management of RETINOSIS PIGMENTARIA

Localizaciones

Stem Cell laboratory, Jinnah Burn & Reconstructive Surgery Centre, Lahore, Punjab, Pakistan

PDE6A Gene Therapy for Retinitis Pigmentosa

Estado: Reclutando Categoria: Retinosis pigmentaria Resultado: No tiene datos

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: subretinal injection of rAAV.hPDE6A

Localizaciones

Universit tsklinikum T bingen, Department f r Augenheilkunde, Tuebingen, Germany

Tamaño de fuente

CONTRASTE

Accessibility by WAH